{
  "meta": {
    "title": "00463_Late_Night_Pyq_Inicet_Medicine-3",
    "url": "https://brainandscalpel.vercel.app/00463-late-night-pyq-inicet-medicine-3-4d01e4bf.html",
    "scrapedAt": "2025-11-29T18:11:19.621Z"
  },
  "questions": [
    {
      "id": 24773,
      "choices": [
        {
          "id": 99053,
          "text": "<p><span style=\"font-size:11.0pt;\">B12 deficiency</span></p>"
        },
        {
          "id": 99054,
          "text": "<p><span style=\"font-size:11.0pt;\">Normal pressure hydrocephalus</span></p>"
        },
        {
          "id": 99055,
          "text": "<p><span style=\"font-size:11.0pt;\">Lewy body dementia</span></p>"
        },
        {
          "id": 99056,
          "text": "<p><span style=\"font-size:11.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is not a cause of reversible dementia? (INICET MAY 2023)</span></p>",
      "unique_key": "Q8060426",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066904,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;Lewy body dementia</strong></span></p><p><br><span style=\"font-size:12pt;\">Lewy body dementia is a progressive and irreversible neurodegenerative disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. B12 deficiency:</strong> Reversible with supplementation.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Normal pressure hydrocephalus:</strong> Reversible with shunting.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hypothyroidism:</strong> Reversible with thyroid hormone replacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Lewy body dementia is not a reversible cause of dementia.</span></p>",
      "correct_choice_id": 99055,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54265,
      "choices": [
        {
          "id": 216529,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aztreonam </span></span></p>"
        },
        {
          "id": 216530,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin </span></span></p>"
        },
        {
          "id": 216531,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone </span></span></p>"
        },
        {
          "id": 216532,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piperacillin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient with a penicillin allergy presents with enterococcal endocarditis. Which of the following drugs can be used safely in this patient?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4437098",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B) Vancomycin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enterococci are gram-positive bacteria, and the first-line treatment for enterococcal infections is typically ampicillin. However, in patients with penicillin allergies, vancomycin is the preferred alternative. Vancomycin is a glycopeptide antibiotic that is effective against gram-positive bacteria, including enterococci. It works by inhibiting cell wall synthesis, leading to bacterial cell death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-102729.jpg\" style=\"height:747px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Linezolid&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tigecycline (Complicated Skin/Intra-abdominal Infections)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Daptomycin</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Aztreonam:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a monobactam antibiotic that is primarily effective against gram-negative bacteria</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">particularly in community-acquired pneumonia in ICU patients with a penicillin allergy, <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aztreonam</span></strong> is the best choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a third-generation cephalosporin antibiotic. While effective against some gram-positive bacteria, it is not the preferred choice for enterococcal infections, especially in patients with penicillin allergies due to the risk of cross-reactivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Piperacillin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a broad-spectrum penicillin antibiotic. It would not be safe to use in a patient with a penicillin allergy due to the risk of a severe allergic reaction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In patients with penicillin allergies who have enterococcal infections, vancomycin is the preferred and safe alternative for treatment.</span></span></span></p>",
      "correct_choice_id": 216530,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24775,
      "choices": [
        {
          "id": 99061,
          "text": "<p><span style=\"font-size:11.0pt;\">25</span></p>"
        },
        {
          "id": 99062,
          "text": "<p><span style=\"font-size:11.0pt;\">68</span></p>"
        },
        {
          "id": 99063,
          "text": "<p><span style=\"font-size:11.0pt;\">35</span></p>"
        },
        {
          "id": 99064,
          "text": "<p><span style=\"font-size:11.0pt;\">43</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient with chronic kidney disease has the following laboratory reports. Calculate the anion gap in this patient. Na<sup>+</sup>: 145 mEq/L, K<sup>+</sup> 4 mEq/L Cl: 90 mEq/L HCO3: 20 mEq/L. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9165858",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066906,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;35</strong></span></p><p><br><span style=\"font-size:12pt;\">The anion gap is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap = Na−(Cl+HCO3)</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Anion&nbsp;Gap=145−(90+20)=35</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The anion gap is calculated as Na - (Cl + HCO3), and a high anion gap may indicate metabolic acidosis.</span></p>",
      "correct_choice_id": 99063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24766,
      "choices": [
        {
          "id": 99025,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular ejection</span></p>"
        },
        {
          "id": 99026,
          "text": "<p><span style=\"font-size:11.0pt;\">Throughout cardiac cycle</span></p>"
        },
        {
          "id": 99027,
          "text": "<p><span style=\"font-size:11.0pt;\">Isovolumetric contraction</span></p>"
        },
        {
          "id": 99028,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular diastole</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">During which phase of the cardiac cycle is an AR murmur likely to be heard? (INICET MAY 2023)</span></p>",
      "unique_key": "Q9470106",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066897,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Ventricular diastole</strong></span></p><p><br><span style=\"font-size:12pt;\">Aortic regurgitation (AR) murmurs are classic early diastolic murmurs heard during ventricular diastole, when blood flows back into the left ventricle from the aorta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Ventricular ejection:</strong> Associated with systolic murmurs.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Throughout cardiac cycle:</strong> Associated with continuous murmurs, like in PDA.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Isovolumetric contraction:</strong> Not typically associated with murmurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aortic regurgitation murmurs are heard during ventricular diastole</span></p>",
      "correct_choice_id": 99028,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54286,
      "choices": [
        {
          "id": 216613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic Interstitial Nephritis</span></span></span></p>"
        },
        {
          "id": 216614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pyelonephritis</span></span></span></p>"
        },
        {
          "id": 216615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berger Disease</span></span></span></p>"
        },
        {
          "id": 216616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urinary Tract Infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 10-year-old child presented with follicular tonsillitis, for which antibiotics were prescribed. In a few days, the child developed flank pain and rash. Peripheral blood demonstrated eosinophilia, and urinalysis showed WBC casts. What is the likely diagnosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3632140",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066871,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Allergic Interstitial Nephritis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allergic interstitial nephritis (AIN), also known as drug-induced interstitial nephritis, is an immune-mediated condition commonly caused by medications such as antibiotics (e.g., penicillins). The clinical presentation of AIN typically includes:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recent medication use:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In this case, antibiotics for follicular tonsillitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flank pain and rash:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These symptoms often develop a few days after starting the medication.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosinophilia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Elevated levels of eosinophils in peripheral blood are a hallmark of allergic reactions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urinalysis findings:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Presence of white blood cell (WBC) casts in the urine indicates renal involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The combination of these symptoms and laboratory findings strongly suggests allergic interstitial nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pyelonephritis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pyelonephritis is characterized by fever, unilateral flank pain, and urinary symptoms like dysuria. It is usually associated with bacterial infection, not with recent antibiotic use or eosinophilia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Berger Disease (IgA Nephropathy):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> IgA nephropathy, or Berger disease, is a glomerulonephritis characterized by hematuria and sometimes proteinuria. It does not typically present with rash, eosinophilia, or WBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Urinary Tract Infection (UTI):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A UTI would present with urinary symptoms such as dysuria, frequency, and urgency. It can also lead to pyelonephritis, but it does not typically cause eosinophilia or WBC casts in the absence of infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allergic interstitial nephritis is characterized by recent medication use (such as antibiotics), flank pain, rash, eosinophilia, and WBC casts in urine. It is an immune-mediated condition commonly caused by drugs, particularly antibiotics.</span></span></p>",
      "correct_choice_id": 216613,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56217,
      "choices": [
        {
          "id": 224285,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 224286,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 224287,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 224288,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What would be seen if the central part of the cord was involved?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">LMN lesion of upper limbs and trunk and UMN of lower limbs.</span></li><li><span style=\"font-size:12.0pt;\">UMN lesion of upper limbs and trunk and LMN of lower limbs.</span></li><li><span style=\"font-size:12.0pt;\">Bladder and bowel involvement.</span></li><li><span style=\"font-size:12.0pt;\">Posterior tract involvement.</span></li></ol>",
      "unique_key": "Q5974792",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066891,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) 1 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cord lesions, such as those seen in conditions like syringomyelia and intramedullary tumors, present with a distinct pattern of neurological deficits due to the anatomical arrangement of the spinal tracts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. LMN lesion of upper limbs and trunk and UMN of lower limbs:</strong> This pattern is common in central cord syndromes, where there is damage to the anterior horn cells leading to lower motor neuron (LMN) lesions in the upper limbs. As the condition progresses, upper motor neuron (UMN) signs may appear in the lower limbs due to the involvement of the corticospinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Bladder and bowel involvement:</strong> Central cord lesions can affect autonomic functions leading to bladder and bowel dysfunction, especially in cases of extensive or progressive lesions like intramedullary tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. UMN lesion of upper limbs and trunk and LMN of lower limbs:</strong> This pattern is not typical for central cord syndromes. Usually, the upper limbs show LMN signs due to the involvement of the anterior horn cells, and the lower limbs show UMN signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Posterior tract involvement:</strong> Posterior tracts, which carry fine touch, vibration, and proprioception, are usually spared in central cord syndromes. These tracts are located more dorsally in the spinal cord, away from the central lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cord lesions, such as syringomyelia, typically present with LMN signs in the upper limbs, UMN signs in the lower limbs, and can involve bladder and bowel dysfunction, but they do not typically affect the posterior tracts</span></p>",
      "correct_choice_id": 224288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54262,
      "choices": [
        {
          "id": 216517,
          "text": "<p><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
        },
        {
          "id": 216518,
          "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
        },
        {
          "id": 216519,
          "text": "<p><span style=\"font-size:12.0pt;\">Evinacumab</span></p>"
        },
        {
          "id": 216520,
          "text": "<p><span style=\"font-size:12.0pt;\">Everolimus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a PCSK-9 inhibitor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2206072",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066924,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Evolocumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK-9 inhibitors are a class of drugs that significantly lower LDL cholesterol levels by inhibiting the protein PCSK-9, which in turn increases the number of LDL receptors available to clear LDL cholesterol from the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are only 2 PCSK-9 inhibitors: Evolocumab and alirocumab. Among the options provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a well-known PCSK-9 inhibitor used in modern clinical practice to manage hyperlipidemia, particularly in patients with familial hypercholesterolemia or those who are at high risk of cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Ezetimibe</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Ezetimibe is an NPC1L1 transport inhibitor, also known as an intestinal cholesterol absorption inhibitor. It reduces blood cholesterol by decreasing the absorption of cholesterol in the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Evinacumab</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Evinacumab is a newer drug that acts as an ANGPTL3 inhibitor. It is specifically approved for use in patients with familial homozygous type 2 hyperlipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Everolimus</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Everolimus is an mTOR inhibitor and an immunosuppressive drug used primarily in organ transplantation and certain types of cancer. It is not related to the treatment of dyslipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a PCSK-9 inhibitor used to significantly lower LDL cholesterol levels, particularly in high-risk patients.</span></p>",
      "correct_choice_id": 216517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54279,
      "choices": [
        {
          "id": 216585,
          "text": "<p><span style=\"font-size:12.0pt;\">11β-Hydroxylase deficiency</span></p>"
        },
        {
          "id": 216586,
          "text": "<p><span style=\"font-size:12.0pt;\">21β-Hydroxylase deficiency</span></p>"
        },
        {
          "id": 216587,
          "text": "<p><span style=\"font-size:12.0pt;\">17β-Hydroxylase deficiency</span></p>"
        },
        {
          "id": 216588,
          "text": "<p><span style=\"font-size:12.0pt;\">SCC deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A tall 10-year-old boy presents with Sexual Maturity Rating 5 and hyperpigmentation. His BP is 150/100 mm Hg. What is the likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2491862",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 11β-Hydroxylase deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation of a tall 10-year-old boy with a Sexual Maturity Rating (SMR) of 5 and hypertension (BP 150/100 mm Hg) indicates precocious puberty. The SMR of 5 typically signifies full sexual maturity, which is unusual for a 10-year-old and suggests precocious puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hyperpigmentation is likely due to elevated ACTH levels, which can occur in congenital adrenal hyperplasia (CAH). The key to the diagnosis is understanding the enzyme deficiencies that lead to CAH and their associated symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">11β-Hydroxylase deficiency leads to increased production of 11-deoxycorticosterone, a mineralocorticoid that causes hypertension due to salt retention. This condition also results in excess androgen production, leading to precocious puberty in boys and virilization in girls.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 21β-Hydroxylase deficiency:</strong> This is the most common cause of CAH but is typically associated with salt-wasting, not hypertension. It results in increased androgen production leading to virilization and ambiguous genitalia in females, and precocious puberty in males.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 17β-Hydroxylase deficiency:</strong> This deficiency is characterized by hypertension and hypokalemia but does not usually cause hyperpigmentation or precocious puberty. It often results in underdeveloped secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SCC (side-chain cleavage) deficiency:</strong> This enzyme deficiency leads to a severe form of CAH with salt-wasting and adrenal insufficiency but is not typically associated with hypertension or hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">11β-Hydroxylase deficiency in congenital adrenal hyperplasia causes hypertension due to salt retention and precocious puberty due to excess androgen production.</span></p>",
      "correct_choice_id": 216585,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54304,
      "choices": [
        {
          "id": 216685,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevation</span></span></span></p>"
        },
        {
          "id": 216686,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adduction</span></span></span></p>"
        },
        {
          "id": 216687,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abduction</span></span></span></p>"
        },
        {
          "id": 216688,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ptosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In CN III palsy, which of the following is not affected?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2516441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066889,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C) Abduction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cranial Nerve III (CN III), also known as the oculomotor nerve, innervates several muscles responsible for eye movements and eyelid elevation. These muscles include the superior rectus (elevation), medial rectus (adduction), inferior rectus (depression), and inferior oblique (extorsion and elevation in adduction). It also innervates the levator palpebrae superioris muscle, which is responsible for elevating the eyelid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">bduction</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is controlled by the lateral rectus muscle, which is innervated by the abducens nerve (CN VI), not the oculomotor nerve. Therefore, abduction is not affected in CN III palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In CN III palsy, the functions of these muscles are compromised, leading to issues such as:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Elevation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">E</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">levation is affected due to the involvement of the superior rectus muscle innervated by CN III.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Adduction</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">A</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">dduction is affected due to the involvement of the medial rectus muscle innervated by CN III.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ptosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">P</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">tosis occurs due to the involvement of the levator palpebrae superioris muscle innervated by CN III.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In CN III palsy, abduction is not affected because it is controlled by the lateral rectus muscle, which is innervated by the abducens nerve (CN VI).</span></span></span></p>",
      "correct_choice_id": 216687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54302,
      "choices": [
        {
          "id": 216677,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
        },
        {
          "id": 216678,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 216679,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
        },
        {
          "id": 216680,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following clinical features can be encountered in Korsakoff psychosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amnesia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Confabulation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ophthalmoplegia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral neuropathy</span></span></span></li>\r\n</ol>",
      "unique_key": "Q2519285",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066887,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) 1, 2, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Korsakoff psychosis, or Korsakoff syndrome, is a chronic neuropsychiatric syndrome resulting from </span><span style=\"font-size:12.0pt\">chronic </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">deficiency </span><span style=\"font-size:12.0pt\">of</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> thiamine (vitamin B1), commonly associated with chronic alcoholism. It is often considered an irreversible condition, unlike its acute counterpart, Wernicke&#39;s encephalopathy, which can be treated with thiamine supplementation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical Features of Korsakoff Psychosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amnesia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Korsakoff syndrome is characterized by severe memory impairment, both anterograde (inability to form new memories) and retrograde (loss of previously formed memories) amnesia. Long-term memory, however, tends to remain relatively intact.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Confabulation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Patients often exhibit confabulation, where they fabricate stories to fill gaps in their memory. This is not intentional lying but a way to compensate for memory loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral Neuropathy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Chronic alcoholics often suffer from peripheral neuropathy due to thiamine deficiency and direct neurotoxic effects of alcohol. This neuropathy involves the axons of peripheral nerves and manifests as numbness, tingling, and pain in the extremities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not a Feature of Korsakoff Psychosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ophthalmoplegia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a feature of Wernicke&#39;s encephalopathy, which presents acutely with a triad of ophthalmoplegia, ataxia, and confusion. Ophthalmoplegia refers to paralysis or weakness of the eye muscles. It is reversible with thiamine treatment and is not typically seen in the chronic phase of Korsakoff syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Korsakoff psychosis is characterized by severe memory impairment (amnesia), confabulation, and peripheral neuropathy. It does not include ophthalmoplegia, which is a feature of the acute Wernicke&#39;s encephalopathy.</span></span></p>",
      "correct_choice_id": 216677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54299,
      "choices": [
        {
          "id": 216665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Age &gt; 50</span></span></span></p>"
        },
        {
          "id": 216666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Temporal tenderness</span></span></span></p>"
        },
        {
          "id": 216667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic Cocaine use</span></span></span></p>"
        },
        {
          "id": 216668,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Subacute progression over 4 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is NOT indicative of underlying serious pathology in headache?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3948735",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066884,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C) Chronic Cocaine use</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While acute cocaine use can lead to serious complications such as intracranial hemorrhage, chronic cocaine use does not typically present as a headache warning sign for serious pathology unless associated with acute episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Age &gt; 50</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: New onset headache in individuals over 50 years of age is a red flag and suggests the possibility of serious conditions such as giant cell arteritis or intracranial mass lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Temporal tenderness</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is often a sign of temporal arteritis (giant cell arteritis), a serious condition that can lead to blindness if not treated promptly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Subacute progression over 4 weeks</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This indicates a progressive condition such as a brain tumor or increased intracranial pressure, which are serious pathologies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic cocaine use is not typically indicative of a serious underlying pathology in headache unless associated with acute episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Headache Symptoms That Suggest a Serious Underlying Disorder</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sudden-onset headache</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">First severe headache</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&quot;Worst&quot; headache ever</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vomiting that precedes headache</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Subacute worsening over days or weeks</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pain induced by bending, lifting, coughing</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pain that disturbs sleep or presents immediately upon awakening</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Known systemic illness</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset after age 55</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fever or unexplained systemic signs</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abnormal neurologic examination</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pain associated with local tenderness, e.g., region of temporal artery</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 216667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24776,
      "choices": [
        {
          "id": 99065,
          "text": "<p><span style=\"font-size:11.0pt;\">Left motor cortex</span></p>"
        },
        {
          "id": 99066,
          "text": "<p><span style=\"font-size:11.0pt;\">Right motor cortex</span></p>"
        },
        {
          "id": 99067,
          "text": "<p><span style=\"font-size:11.0pt;\">Left posterior parietal area</span></p>"
        },
        {
          "id": 99068,
          "text": "<p><span style=\"font-size:11.0pt;\">Right posterior parietal area</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A person comes to the OPD with symptoms of not using his left side and not washing the left side of his body while bathing. On examination he wasn't able to draw the left side of the images. Which of the following is the most likely location of the lesion? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152753.png\" alt=\"\" width=\"300\" height=\"293\"></span></p>",
      "unique_key": "Q6628804",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066907,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Right posterior parietal area</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms described indicate left-sided hemi-neglect, which is typically due to a lesion in the non-dominant (right) posterior parietal area, responsible for spatial awareness and attention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Left motor cortex:</strong> Would result in right-sided motor deficits.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Right motor cortex:</strong> Would result in left-sided motor deficits but not neglect.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Left posterior parietal area:</strong> Would result in right-sided hemi-neglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Left-sided neglect is often due to a lesion in the right posterior parietal area.</span></p>",
      "correct_choice_id": 99068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54282,
      "choices": [
        {
          "id": 216597,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone</span></p>"
        },
        {
          "id": 216598,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 216599,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 216600,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman, having lost her newborn, is producing breast milk, which risks developing into a breast abscess due to milk stasis and incomplete emptying. Which drug can prevent this complication?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7693853",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066867,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this scenario, the primary goal is to suppress lactation to prevent milk stasis and subsequent breast abscess formation. Lactation is driven by the hormone prolactin, which is released from the anterior pituitary gland. To suppress milk production, prolactin release must be inhibited.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cabergoline is a dopamine receptor agonist that works by stimulating dopamine receptors, which in turn inhibits prolactin secretion from the anterior pituitary gland. By reducing prolactin levels, cabergoline effectively suppresses lactation, thereby reducing the risk of milk stasis and breast abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mifepristone:</strong> This drug is a progesterone receptor antagonist primarily used for medical termination of pregnancy. It does not have a role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chlorpromazine:</strong> This is an antipsychotic medication that blocks dopamine D2 receptors. Blocking dopamine receptors would actually increase prolactin levels and promote milk production, thus potentially worsening the risk of milk stasis and abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metoclopramide:</strong> This drug is a dopamine D2 receptor antagonist and is sometimes used as a galactagogue (to promote milk production). Like chlorpromazine, it would increase prolactin levels and thus is not suitable for preventing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cabergoline, a dopamine receptor agonist, is used to suppress lactation by inhibiting prolactin secretion, thereby preventing complications like milk stasis and breast abscess.</span></p>",
      "correct_choice_id": 216598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54280,
      "choices": [
        {
          "id": 216589,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper</span></p>"
        },
        {
          "id": 216590,
          "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
        },
        {
          "id": 216591,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenium</span></p>"
        },
        {
          "id": 216592,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Decreased sexual maturity and hypogonadism seen with deficiency of:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9512339",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066865,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Zinc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc is an essential trace element involved in numerous aspects of cellular metabolism. It plays a vital role in immune function, protein synthesis, wound healing, DNA synthesis, and cell division. Zinc is also crucial for normal growth and development during pregnancy, childhood, and adolescence, and it is necessary for the proper functioning of taste and smell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Features of Zinc Deficiency:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Decreased Sexual Maturity:</strong> Zinc deficiency in children and adolescents can lead to growth retardation and delayed sexual maturation, particularly hypogonadism in males.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypogonadism:</strong> This condition is characterized by the underdevelopment of primary or secondary sexual characteristics, such as the testes in males, leading to delayed or absent puberty.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Impaired Immune Function:</strong> Zinc deficiency can result in an increased susceptibility to infections.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other Symptoms:</strong> Include hair loss, diarrhea, delayed wound healing, and eye and skin lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Copper:</strong> Deficiency can lead to anemia (microcytic, hypochromic), neutropenia, bone abnormalities, and neurological issues such as peripheral neuropathy and subacute combined degeneration of the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Selenium:</strong> Deficiency can cause Keshan disease (a type of cardiomyopathy) and Kashin-Beck disease (a type of osteoarthropathy).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Iron:</strong> Deficiency is commonly associated with microcytic, hypochromic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zinc deficiency is associated with decreased sexual maturity and hypogonadism, particularly in male children, and is a common nutritional deficiency in developing countries. It is also linked to impaired growth, immune dysfunction, and delayed wound healing.</span></p>",
      "correct_choice_id": 216590,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24779,
      "choices": [
        {
          "id": 99077,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
        },
        {
          "id": 99078,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 99079,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4,5</span></p>"
        },
        {
          "id": 99080,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4,5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are true about subclinical myocarditis? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Palpitations</span></li><li><span style=\"font-size:12.0pt;\">Elevated BNP Troponins</span></li><li><span style=\"font-size:12.0pt;\">Regional wall motion abnormalities in echo</span></li><li><span style=\"font-size:12.0pt;\">ECG suggestive of myocarditis</span></li><li><span style=\"font-size:12.0pt;\">Low LVEF in echo</span></li></ol>",
      "unique_key": "Q9009228",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066910,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4,5</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Subclinical myocarditis may not present with symptoms like palpitations, but can show:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. Elevated BNP/Troponins: Indicating myocardial injury.</span></p><p><span style=\"font-size:12.0pt;\">3. Regional wall motion abnormalities: Seen on echocardiography.</span></p><p><span style=\"font-size:12.0pt;\">4. ECG changes: Suggestive of myocarditis, such as non-specific ST-T changes.</span></p><p><span style=\"font-size:12.0pt;\">5. Low LVEF: Indicative of impaired left ventricular function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Palpitations are not a feature of subclinical myocarditis.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subclinical myocarditis can present with elevated cardiac biomarkers, regional wall motion abnormalities, ECG changes, and reduced LVEF, but not Palpitations, which is common in viral myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Past common causes of myocarditis: Coxsackie virus types A and B.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Currently, Most common cause of myocarditis: Parvovirus B19 and HHV6.</span></p>",
      "correct_choice_id": 99080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11620,
      "choices": [
        {
          "id": 46446,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcified valve</span></p>"
        },
        {
          "id": 46447,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        },
        {
          "id": 46448,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 46449,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild mitral stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The absence of loud S1 in mitral stenosis would indicate all of the following, except:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9445488",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066916,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Mild mitral stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first heart sound (S1) is produced by the closure of the mitral and tricuspid valves at the beginning of systole. In mitral stenosis, the loudness of S1 can vary depending on several factors. A loud S1 is typically associated with the early stages of mitral stenosis when the valve leaflets are still relatively mobile. However, in certain conditions, S1 can become softer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mild mitral stenosis without significant calcification usually results in a loud S1. This is because the mitral valve leaflets are still relatively mobile and can close forcefully. Therefore, mild mitral stenosis is the correct exception in this context, as it does not typically cause a soft S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Calcified valve:</strong> When the mitral valve becomes calcified, it loses its mobility. This results in a softer S1 because the valve leaflets are not able to close rapidly or forcefully.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aortic regurgitation:</strong> Aortic regurgitation can lead to an increased preload in the left ventricle, which can in turn affect the closure of the mitral valve, making S1 softer. Additionally, mitral regurgitation, which often coexists with mitral stenosis, can also soften S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. First degree heart block:</strong> In first degree AV block, there is a prolonged PR interval. This delayed conduction can lead to a less forceful closure of the mitral valve, resulting in a softer S1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In mitral stenosis, a loud S1 is typically seen in the early stages with mobile valves, while a soft S1 can indicate valve calcification, aortic regurgitation, or first degree heart block. Mild mitral stenosis without calcification usually results in a loud S1</span></p>",
      "correct_choice_id": 46449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24772,
      "choices": [
        {
          "id": 99049,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti HBs&nbsp;&nbsp;&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 99050,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti HBc</span></p>"
        },
        {
          "id": 99051,
          "text": "<p><span style=\"font-size:11.0pt;\">HBeAg</span></p>"
        },
        {
          "id": 99052,
          "text": "<p><span style=\"font-size:11.0pt;\">HBsAg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient recovered from hepatitis B infection. Which of the following curve represents antibodies seen 4 weeks post-recovery? (INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152209.png\" alt=\"\" width=\"300\" height=\"147\"></span></p>",
      "unique_key": "Q7529703",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066903,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Anti HBs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After recovery from hepatitis B infection, the patient will have antibodies against the hepatitis B surface antigen (anti-HBS), indicating immunity. The key points related to hepatitis B infection and recovery include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBsAg (Hepatitis B surface antigen):</strong> Initially present during the acute phase of infection, indicating active infection. It will eventually drop and become negative upon recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-HBc (Hepatitis B core antibody):</strong> Initially, anti-HBc IgM is positive during the acute phase, which then transitions to anti-HBc IgG as the infection progresses. The total anti-HBc represents both IgM initially and IgG later on.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBeAg (Hepatitis B e antigen):</strong> Indicates active viral replication and high infectivity. It decreases as the virus is cleared.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Anti-HBs (Hepatitis B surface antibody):</strong> The protective antibody indicating recovery and immunity from hepatitis B infection. This antibody appears after the disappearance of HBsAg and is a marker of immunity post-recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anti HBc</strong>: Anti-HBc indicates past or current infection with hepatitis B. Initially, IgM anti-HBc is present during the acute infection, and later, IgG anti-HBc persists. However, it does not specifically indicate recovery and immunity.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. HBeAg</strong>: HBeAg is a marker of active viral replication and high infectivity. It is present during the active infection phase and decreases as the infection resolves.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option D. HBsAg:</strong> HBsAg indicates active hepatitis B infection. It is present during the acute phase of infection and disappears upon recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-HBs antibodies indicate recovery and immunity from hepatitis B infection. This is the only protective antibody that signifies the patient has successfully recovered from the infection and has developed immunity.</span></p>",
      "correct_choice_id": 99049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54301,
      "choices": [
        {
          "id": 216673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir</span></span></span></p>"
        },
        {
          "id": 216674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids</span></span></span></p>"
        },
        {
          "id": 216675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics</span></span></span></p>"
        },
        {
          "id": 216676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 40-year-old patient presented with left facial weakness. Routine lab workup was normal. What is the next best step in management?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6451864",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Corticosteroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presentation of left facial weakness with normal routine lab workup suggests Bell&#39;s palsy, an idiopathic condition characterized by sudden onset of unilateral lower motor neuron facial paralysis. Bell&#39;s palsy is a diagnosis of exclusion and is the most common cause of unilateral facial paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The first-line treatment for Bell&#39;s palsy is corticosteroids. They are most effective when started within 72 hours of symptom onset. Early treatment with corticosteroids can significantly improve the chances of complete recovery. A typical regimen is prednisolone or prednisone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Prednisone 60-80 mg per day for 5-7 days, followed by a taper over the next 5-7 days.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note &ndash; In t</span><span style=\"font-size:12.0pt\">he severity grading system, <strong>House-Brackmann grading</strong>, if the patient has <strong>Grade 4 or Grade 5</strong> severity, consider adding <strong>antivirals</strong> such as <strong>acyclovir</strong> or <strong>valacyclovir</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although acyclovir or other antiviral agents like valacyclovir are sometimes used, their benefit is less clear. They may be considered in severe cases of Bell&#39;s palsy, particularly when there is a suspicion of herpes simplex virus involvement, but they are not the primary treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Valacyclovir 1 gram TID for 7 days or acyclovir 400 mg five times a day for 7-10 days.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note - </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valacyclovir</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> has superior bioavailability, superior efficacy, and lower side effects compared to <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">acyclovir</span></strong><strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There is no role for antibiotics in the treatment of Bell&#39;s palsy as it is not caused by a bacterial infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While physiotherapy, including facial exercises and eye protection measures, can be supportive, it is not the primary treatment and should be considered an adjunct to corticosteroid therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best initial management for a patient with Bell&#39;s palsy is corticosteroid therapy. Early administration within 72 hours of symptom onset greatly enhances the likelihood of complete recovery. Antivirals may be added in severe cases, but they are not the mainstay of treatment.</span></span></p>",
      "correct_choice_id": 216674,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54291,
      "choices": [
        {
          "id": 216633,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b</span></p>"
        },
        {
          "id": 216634,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c</span></p>"
        },
        {
          "id": 216635,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 216636,
          "text": "<p><span style=\"font-size:12.0pt;\">Only b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin is secreted by which of the following?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Liver</span><br><span style=\"font-size:12.0pt;\">b. Kidney</span><br><span style=\"font-size:12.0pt;\">c. Spleen</span><br><span style=\"font-size:12.0pt;\">d. Heart</span></p>",
      "unique_key": "Q5540668",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066876,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) a, b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin (EPO) is a hormone responsible for stimulating the production of red blood cells in the bone marrow. The primary source of erythropoietin in the human body is the kidney, which accounts for about 90% of its production. The liver contributes approximately 10% of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Liver:</strong> The liver produces erythropoietin mainly during fetal development, and its contribution decreases postnatally, although it continues to produce a small amount in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Kidney:</strong> Erythropoietin is mainly produced by <strong>interstitial fibroblast-like cells located in the renal cortex, particularly near the proximal convoluted tubules.</strong> The production of EPO in the kidneys is primarily regulated by oxygen levels; hypoxia (low oxygen levels) stimulates its secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spleen and heart are not known sources of erythropoietin production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option c &amp; d:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Neither the spleen nor the heart produce erythropoietin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythropoietin is primarily produced by the kidneys (90%) and to a lesser extent by the liver (10%). These organs are the main sources of erythropoietin in the human body, with the kidneys playing a dominant role in its regulation and production in response to hypoxia.</span></p>",
      "correct_choice_id": 216633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24765,
      "choices": [
        {
          "id": 99021,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti-U3 RNP</span></p>"
        },
        {
          "id": 99022,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti-centromere antibody</span></p>"
        },
        {
          "id": 99023,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti-PM-Scl antibody</span></p>"
        },
        {
          "id": 99024,
          "text": "<p><span style=\"font-size:11.0pt;\">Anti-Jo-1 antibody</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 35-year-old female presents with skin thickening muscle weakness and the peripheries becoming pale on exposure to cold. She is positive for ANA and anti-Scl-70 antibodies. Her creatinine kinase is elevated and muscle biopsy shows perifascicular infiltration. What is the antibody associated with this? (INICET MAY 2023)</span></p>",
      "unique_key": "Q8401708",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066896,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)&nbsp;Anti-PM-Scl antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with features of scleroderma and dermatomyositis overlap syndrome. Anti-PM-Scl antibody is associated with this overlap syndrome, tends to produce nucleolar pattern in your ANA immunofluorescence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Anti-U3 RNP:</strong> Associated with the diffuse form of scleroderma and are also known as anti-fibrillarin antibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anti-centromere antibody:</strong> Associated with limited scleroderma (CREST syndrome).</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anti-Jo-1 antibody:</strong> Associated with antisynthetase syndrome, which predominantly causes interstitial lung disease (ILD), mechanic's hands, myositis, and Raynaud's phenomenon. It is not associated with scleroderma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-PM-Scl antibody is associated with overlap syndromes involving scleroderma and myositis.</span></p>",
      "correct_choice_id": 99023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54285,
      "choices": [
        {
          "id": 216609,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Renal Blood Flow</span></p>"
        },
        {
          "id": 216610,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Glomerular hydrostatic pressure</span></p>"
        },
        {
          "id": 216611,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Bowman's oncotic pressure</span></p>"
        },
        {
          "id": 216612,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased Glomerular oncotic pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A decrease in GFR is associated with which of the following?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3009609",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreased Bowman's oncotic pressure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the hydrostatic pressure of the capillaries or the oncotic pressure of the Bowman's capsule decreases, filtration will decrease. If the oncotic pressure in the glomerular capillary increases or if the hydrostatic pressure in the Bowman's capsule increases, GFR will decrease as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glomerular filtration rate (GFR) is determined by the net filtration pressure, which depends on various pressures within the glomerulus and Bowman's capsule:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased Renal Blood Flow:</strong> This increases GFR as more blood flow leads to higher filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increased Glomerular Hydrostatic Pressure:</strong> This also increases GFR because higher pressure in the glomerulus drives more filtrate into Bowman's capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased Glomerular Oncotic Pressure:</strong> This increases GFR because lower protein concentration in the glomerulus reduces the opposing force to filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreased Bowman's capsule oncotic pressure reduces net filtration pressure (NFP) and decreases glomerular filtration rate (GFR). Increased Bowman's capsule oncotic pressure increases filtration pressure and GFR.</span></p>",
      "correct_choice_id": 216611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54258,
      "choices": [
        {
          "id": 216501,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsus Paradoxus is usually seen</span></p>"
        },
        {
          "id": 216502,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardiocentesis may be required</span></p>"
        },
        {
          "id": 216503,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1 is a common finding</span></p>"
        },
        {
          "id": 216504,
          "text": "<p><span style=\"font-size:12.0pt;\">Echo will show diastolic RA/RV collapse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a history of chest pain and upper respiratory tract infection, seven days ago, presents with shortness of breath. She has BP of 100/60 mm Hg and a pulse rate of 110/min. Chest x-ray reviews an enlarged heart, which appears like a water bottle. Which of the following is incorrect?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5137273",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066920,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Loud S1 is a common finding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is likely suffering from <strong>pericardial effusion</strong>, possibly progressing to cardiac tamponade, secondary to a recent viral infection. This is suggested by the history of an upper respiratory tract infection, the physical findings, and the characteristic \"water bottle\" appearance of the heart on the chest x-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The incorrect statement is <strong>Loud S1 is a common finding</strong>. In fact, one of the hallmarks of cardiac tamponade is <strong>muffled or distant heart sounds</strong> due to the insulating effect of the pericardial fluid, as described in Beck's triad, which includes hypotension, jugular venous distension, and muffled heart sounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulsus Paradoxus is usually seen:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pulsus paradoxus is a significant drop in blood pressure during inspiration, common in cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pericardiocentesis may be required:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. Pericardiocentesis is often necessary to remove the excess fluid and relieve pressure on the heart, especially if the patient is hemodynamically unstable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Echo will show diastolic RA/RV collapse:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">This is true. In cardiac tamponade, the pressure from the pericardial fluid prevents the right atrium and right ventricle from expanding during diastole, leading to their collapse.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Echocardiography will reveal this diastolic collapse, confirming cardiac tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cardiac tamponade, muffled heart sounds are a key finding, not a loud S1.</span></p>",
      "correct_choice_id": 216503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54263,
      "choices": [
        {
          "id": 216521,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 216522,
          "text": "<p><span style=\"font-size:12.0pt;\">Lepirudin</span></p>"
        },
        {
          "id": 216523,
          "text": "<p><span style=\"font-size:12.0pt;\">Fondaparinux</span></p>"
        },
        {
          "id": 216524,
          "text": "<p><span style=\"font-size:12.0pt;\">Dabigatran</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anticoagulants requires coagulation profile monitoring?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3370230",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Lepirudin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin is a parenteral direct thrombin inhibitor, which requires routine coagulation profile monitoring. The standard test used for monitoring Lepirudin is the activated partial thromboplastin time (aPTT). In cath labs, when administering in high doses need to be monitor with ACT (Activated Clotting Time) rather than aPTT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is necessary to ensure the correct therapeutic range is maintained and to avoid complications such as bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - There are four parenteral direct thrombin inhibitors: lepirudin, hirudin, bivalirudin, and argatroban.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Enoxaparin</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Enoxaparin is a low molecular weight heparin (LMWH). It has a predictable anticoagulant effect, and routine coagulation monitoring is generally not required under standard clinical circumstances. In special situations, monitoring can be done using anti-factor Xa levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Fondaparinux</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Fondaparinux, like Enoxaparin, does not typically require routine coagulation monitoring due to its predictable pharmacokinetics and pharmacodynamics. In specific clinical scenarios, anti-factor Xa levels may be measured.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Dabigatran</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Dabigatran is an oral direct thrombin inhibitor and is classified under direct oral anticoagulants (DOACs). Routine coagulation monitoring is not required due to its reliable and predictable effects. However, if monitoring is needed, aPTT can be used, though more specific tests like the dilute thrombin time (dTT) or the ecarin clotting time (ECT) are preferred for accurate measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>- There are four DOACs (Direct Oral Anticoagulants): Dabigatran (direct thrombin inhibitor), Apixaban, Rivaroxaban and Edoxaban (all 3 are factor Xa inhibitor)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lepirudin, a parenteral direct thrombin inhibitor, requires routine coagulation profile monitoring using aPTT to ensure therapeutic efficacy and safety.</span></p>",
      "correct_choice_id": 216522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11616,
      "choices": [
        {
          "id": 46430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce FiO2</span></span></span></p>"
        },
        {
          "id": 46431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase tidal volume</span></span></span></p>"
        },
        {
          "id": 46432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase respiratory rate</span></span></span></p>"
        },
        {
          "id": 46433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase PEEP</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old female patient weighing 60 kg is on mechanical ventilation for ARDS secondary to urosepsis.&nbsp;</span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">The respiratory parameters are as follows: tidal volume- 360 mL; frequency- 30 breaths/min; PEEP- 5 cm of H2O; and FiO2- 90%.&nbsp;</span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arterial blood gas findings are as follows: paO2- 50 mmHg; paCO2- 38 mmHg and pH- 7.38.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the next step?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q4970510",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066915,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase PEEP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS) requires careful management of mechanical ventilation settings to optimize oxygenation while minimizing lung injury. The patient&#39;s current settings and blood gas findings suggest hypoxemia (paO2 of 50 mmHg) with an FiO2 of 90%. The goal in managing ARDS is to maintain adequate oxygenation (paO2 &gt; 60 mmHg) while reducing the FiO2 to less than 60% to avoid oxygen toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increasing PEEP is the best option to improve oxygenation. PEEP helps to keep alveoli open, improving gas exchange and oxygenation. By increasing PEEP, we can potentially increase the paO2 and eventually reduce the FiO2 to safer levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Reduce FiO2</strong>: Although reducing FiO2 is a long-term goal to prevent oxygen toxicity, it is not advisable to reduce it immediately because the patient is currently hypoxemic (paO2 of 50 mmHg).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase tidal volume</strong>: Not appropriate as it can increase the risk of ventilator-induced lung injury in ARDS patients. The current tidal volume is within the safe range (360 mL), which is appropriate for a 60 kg patient as it falls within the recommended range of 4-6 mL/kg for ARDS patients to prevent ventilator-induced lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase respiratory rate</strong>: Increasing the respiratory rate is not necessary in this situation as the paCO2 (38 mmHg) and pH (7.38) indicate normal ventilation and no significant respiratory acidosis (paCO2 is normal).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In ARDS management, if the patient remains hypoxemic despite a high FiO2, the next step is to increase the PEEP to improve oxygenation while maintaining lung-protective ventilation strategies.</span></span></span></p>",
      "correct_choice_id": 46433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56213,
      "choices": [
        {
          "id": 224269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High HDV viral load</span></span></span></p>"
        },
        {
          "id": 224270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of Anti-HBc IgM antibodies</span></span></span></p>"
        },
        {
          "id": 224271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of IgM anti-HDV antibodies</span></span></span></p>"
        },
        {
          "id": 224272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Presence of Anti-HBc IgG antibodies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serologic findings of a patient with hepatitis are given below. HBsAg positive, Anti-HBc (total) positive, Anti-HDV (total) positive. Which of the following is most useful in diagnosing HDV co-infection over superinfection?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q5486419",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Presence of Anti-HBc IgM antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To differentiate between HDV co-infection and superinfection, it is essential to understand the nature of these infections:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Co-infection&nbsp;</span></strong><span style=\"font-size:12.0pt\">occurs when a patient acquires both acute HBV and acute HDV simultaneously. The presence of <strong>Anti-HBc IgM antibodies</strong> indicates a recent acute HBV infection, which is characteristic of co-infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Superinfection&nbsp;</span></strong><span style=\"font-size:12.0pt\">occurs when a patient with chronic HBV infection acquires an acute HDV infection. In this scenario, the patient has markers of chronic HBV (like <strong>Anti-HBc IgG</strong> <strong>antibodies</strong>) along with markers of acute HDV infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Anti-HBc IgM antibodies</strong> are indicative of an acute HBV infection and are useful for diagnosing co-infection because they show that the HBV infection is recent, which aligns with the scenario of both HBV and HDV being acquired simultaneously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>High HDV viral load</strong>: This can be present in both co-infection and superinfection and does not specifically differentiate between the two.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Presence of IgM anti-HDV antibodies</strong>: These antibodies can be present in both co-infection and superinfection as they indicate an acute HDV infection. Therefore, they are not useful in differentiating between the two conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Presence of Anti-HBc IgG antibodies</strong>: This indicates a past or chronic HBV infection. The presence of Anti-HBc IgG is more consistent with superinfection rather than co-infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of Anti-HBc IgM antibodies is most useful in diagnosing HDV co-infection over superinfection because it indicates a recent acute HBV infection, which is characteristic of co-infection.</span></span></span></p>",
      "correct_choice_id": 224270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54297,
      "choices": [
        {
          "id": 216657,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyper-reflexia</span></span></span></p>"
        },
        {
          "id": 216658,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atrophy</span></span></span></p>"
        },
        {
          "id": 216659,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rigidity</span></span></span></p>"
        },
        {
          "id": 216660,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fasciculations</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is seen in UMN (Upper Motor Neuron) weakness?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3900886",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Hyper-reflexia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Upper Motor Neuron (UMN) lesions are associated with a specific set of clinical features due to the disruption of the central motor pathways that originate in the cerebral cortex and descend through the brainstem and spinal cord to synapse on the lower motor neurons. The key features of UMN lesions include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyper-reflexia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is characterized by exaggerated deep tendon reflexes. The loss of inhibitory modulation from the cortex leads to an overactive reflex arc.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spasticity:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Increased muscle tone that is velocity-dependent, often seen in conjunction with hyper-reflexia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Babinski sign:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> An abnormal reflex where the big toe extends upward when the sole of the foot is stimulated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No significant muscle atrophy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While mild disuse atrophy can occur over time, it is not as pronounced as in lower motor neuron (LMN) lesions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No fasciculations:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Fasciculations, or spontaneous contractions of muscle fibers, are indicative of LMN lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Atrophy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Significant muscle atrophy is a <strong>hallmark of LMN lesions</strong> due to denervation of the muscles. It is not typically seen in UMN lesions except for mild disuse atrophy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Rigidity:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Rigidity is associated with <strong>extrapyramidal disorders</strong>, such as Parkinson&#39;s disease, and is characterized by increased muscle tone that is uniform and not velocity-dependent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Fasciculations:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Fasciculations are <strong>indicative of LMN lesions</strong> and result from spontaneous depolarization of lower motor neurons.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The hallmark feature of Upper Motor Neuron (UMN) weakness is hyper-reflexia, characterized by exaggerated deep tendon reflexes. This occurs due to the loss of inhibitory control from the brain on the reflex arcs in the spinal cord.</span></span></span></p>",
      "correct_choice_id": 216657,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54276,
      "choices": [
        {
          "id": 216573,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteonecrosis of the jaw bone</span></p>"
        },
        {
          "id": 216574,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
        },
        {
          "id": 216575,
          "text": "<p><span style=\"font-size:12.0pt;\">Subtrochanteric fracture</span></p>"
        },
        {
          "id": 216576,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of bone mass</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an adverse effect associated with the long-term use of intermittent teriparatide for the treatment of osteoporosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4087520",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066862,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Osteosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Teriparatide is a recombinant form of parathyroid hormone (PTH) used as an anabolic (bone-building) agent in the treatment of osteoporosis. It is administered via daily subcutaneous injections. While effective in increasing bone mass and reducing fracture risk, the long-term use of teriparatide has been associated with certain risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Osteosarcoma is a type of bone cancer that has been linked to the long-term use of teriparatide in animal studies. Specifically, when used for more than two years, there is evidence from these studies suggesting an increased risk of developing osteosarcoma. This potential risk has led to a restriction on the duration of teriparatide therapy to a maximum of two years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osteonecrosis of the jaw bone:</strong> This condition is a known adverse effect of bisphosphonates, not teriparatide. Bisphosphonates can lead to decreased blood flow to the jawbone, causing osteonecrosis, especially following dental procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Subtrochanteric fracture (atypical femoral fracture):</strong> This type of fracture is also associated with long-term use of bisphosphonates, rather than teriparatide. Bisphosphonates may alter bone remodeling, leading to atypical fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Loss of bone mass:</strong> Teriparatide is an anabolic agent that actually increases bone mass. Bisphosphonates also prevent bone mass loss by inhibiting osteoclast-mediated bone resorption. Thus, loss of bone mass is not associated with either teriparatide or bisphosphonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The long-term use of teriparatide is associated with an increased risk of osteosarcoma, which is why its use is limited to a maximum of <strong>two years.</strong></span></p>",
      "correct_choice_id": 216574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54295,
      "choices": [
        {
          "id": 216649,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Triple Phosphate</span></span></span></p>"
        },
        {
          "id": 216650,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium oxalate</span></span></span></p>"
        },
        {
          "id": 216651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystine</span></span></span></p>"
        },
        {
          "id": 216652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uric acid</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the crystal in a patient with urinary pH of 8.7:</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-130550.jpg\" style=\"height:300px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q7118993",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066880,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Triple Phosphate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Normally, urinary pH typically ranges from <strong>4.4 to 6.5</strong>, which is acidic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Here, a</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">n alkaline urinary pH of 8.7 promotes the formation of certain types of crystals, particularly <strong>triple phosphate (struvite) and calcium phosphate crystals</strong>. The image provided shows typical <strong>&quot;coffin-lid&quot; shaped crystals</strong>, which are characteristic of triple phosphate (magnesium ammonium phosphate) or struvite crystals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Triple Phosphate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> crystals are commonly associated with urinary tract infections caused by urease-positive bacteria such as <em>Proteus</em>, <em>Klebsiella</em>, and <em>Ureaplasma urealyticum</em>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Calcium Oxalate :</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These crystals typically form in acidic urine and have different shapes, such as envelope or dumbbell shapes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Cystine :</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These crystals also form in acidic urine and have a distinctive hexagonal shape.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Uric Acid :</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These crystals form in acidic urine and appear as rhomboid or rosette shapes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Triple phosphate (struvite) crystals are associated with alkaline urine and have a &quot;coffin-lid&quot; appearance. They are commonly seen in patients with urinary tract infections caused by urease-positive organisms.</span></span></span></p>",
      "correct_choice_id": 216649,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54260,
      "choices": [
        {
          "id": 216509,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Almost never seen in heart with normal morphology</span></span></p>"
        },
        {
          "id": 216510,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV Digoxin can be used for ventricular rate control</span></span></p>"
        },
        {
          "id": 216511,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC Cardioversion is required in all cases</span></span></p>"
        },
        {
          "id": 216512,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discrepancy in HR and PR is a clinically reliable criteria for diagnosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 38-year-old man collapsed and was brought to the emergency. ECG was taken and a diagnosis of atrial fibrillation (AF) was made. Which of the following is true?</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101221.jpg\" style=\"height:248px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q7883146",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066922,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B) IV Digoxin can be used for ventricular rate control</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atrial fibrillation (AF) is characterized by an irregularly irregular rhythm without distinct P waves on ECG, which confirms the diagnosis. Each of the provided options needs to be evaluated for accuracy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IV Digoxin can be used for ventricular rate control</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is the correct statement. IV Digoxin is used for rate control in AF, particularly in patients with heart failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If the patient is stable and not in acute heart failure, beta-blockers or non-dihydropyridine calcium channel blockers like verapamil or diltiazem are preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Almost never seen in heart with normal morphology</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This statement is incorrect. Atrial fibrillation can occur in morphologically normal hearts. Studies indicate that 15-35% of AF cases can be seen in individuals with structurally normal hearts, although it is more common in those with conditions such as heart failure or left atrial enlargement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><strong style=\"font-size:11pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DC Cardioversion is required in all cases</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">:</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.6667px; font-style:normal\">&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">This statement is incorrect. DC cardioversion is reserved for unstable patients or for rhythm control in selected chronic cases. It is not required for all AF cases.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-family:Calibri,sans-serif\"><strong style=\"font-size:11pt\"><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong style=\"font-size:11pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Discrepancy in HR and PR is a clinically reliable criteria for diagnosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">:</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.6667px; font-style:normal\">&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\">This statement is incorrect. While a pulse deficit (difference between heart rate and pulse rate) can suggest AF, it is not a reliable diagnostic criterion as it can be observed in other conditions such as frequent ventricular premature contractions, cardiac tamponade, and severe heart failure.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV Digoxin can be effectively used for ventricular rate control in patients with atrial fibrillation, especially in those with heart failure.</span></span></p>",
      "correct_choice_id": 216510,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56215,
      "choices": [
        {
          "id": 224277,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retrolentiform</span></span></p>"
        },
        {
          "id": 224278,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sublentiform</span></span></p>"
        },
        {
          "id": 224279,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior limb</span></span></p>"
        },
        {
          "id": 224280,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior limb</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male patient presented with left-sided hemiparesis. Damage to which part of the internal capsule leads to this presentation?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2022)</span></span></p>",
      "unique_key": "Q1586147",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Posterior limb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The internal capsule is a white matter structure in the brain that contains many important tracts, including those for motor and sensory functions. Damage to specific parts of the internal capsule can result in different clinical presentations based on the fibers that are affected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Posterior limb</span></strong><span style=\"font-size:12.0pt\"> is the part of the internal capsule that carries corticospinal and corticobulbar tracts, which are responsible for motor and sensory functions. Damage to the posterior limb can result in contralateral hemiparesis (weakness on the opposite side of the body). Therefore, a lesion in the posterior limb of the right internal capsule would lead to left-sided hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Retrolentiform</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains optic radiations, which are involved in visual processing. Damage here would lead to <strong>visual deficits</strong> rather than motor or sensory deficits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sublentiform</span></strong><span style=\"font-size:12.0pt\">: This part carries auditory radiations and is involved in hearing. Damage to this part would result in <strong>auditory deficits,</strong> not motor weakness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anterior limb</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains frontopontine fibers and thalamocortical radiations, which are involved in <strong>cognitive and executive functions</strong>. Damage here might affect cognition but not typically result in hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Damage to the posterior limb of the internal capsule can lead to contralateral hemiparesis due to the involvement of motor and sensory pathways.</span></span></span></p>",
      "correct_choice_id": 224280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54274,
      "choices": [
        {
          "id": 216565,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></p>"
        },
        {
          "id": 216566,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></p>"
        },
        {
          "id": 216567,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></p>"
        },
        {
          "id": 216568,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old patient with heart failure and poorly controlled type 2 diabetes (HbA1c of 7.8%) presents with progressive dyspnea. Which is the preferred antidiabetic drug?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8718982",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066860,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that has shown significant benefits in patients with heart failure, particularly heart failure with reduced ejection fraction (HFrEF). SGLT2 inhibitors, including dapagliflozin and empagliflozin, have been demonstrated to improve survival, reduce heart failure hospitalizations, and delay the progression of heart failure. These benefits make SGLT2 inhibitors the preferred choice for patients with both type 2 diabetes and heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Four Pillars in the Management of HFrEF (Heart Failure with Reduced Ejection Fraction):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ARNIs and ACE Inhibitors/ARBs</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ARNIs (e.g., Sacubitril/Valsartan) are preferred.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE Inhibitors/ARBs are also used.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Beta Blockers</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bisoprolol</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carvedilol</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MRAs (Mineralocorticoid Receptor Antagonists)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spironolactone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eplerenone</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SGLT2 Inhibitors</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Empagliflozin</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapagliflozin</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Glimepiride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a sulfonylurea that primarily helps in lowering blood glucose by stimulating insulin secretion. It does not provide the cardiovascular benefits seen with SGLT2 inhibitors and can increase the risk of hypoglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Metformin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While metformin is a first-line therapy for type 2 diabetes and has some cardiovascular benefits, it is not specifically indicated for improving heart failure outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sitagliptin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage blood glucose levels. It does not provide the same level of heart failure benefit as SGLT2 inhibitors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For patients with type 2 diabetes and heart failure, SGLT2 inhibitors like dapagliflozin are the preferred antidiabetic medications due to their proven benefits in reducing heart failure progression, hospitalizations, and mortality.</span></span></span></p>",
      "correct_choice_id": 216565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54284,
      "choices": [
        {
          "id": 216605,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft tissue tumour in orbit</span></p>"
        },
        {
          "id": 216606,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid eye disease</span></p>"
        },
        {
          "id": 216607,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve meningioma</span></p>"
        },
        {
          "id": 216608,
          "text": "<p><span style=\"font-size:12.0pt;\">Cavernous hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common cause of proptosis in a middle-aged person?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3439441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066869,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thyroid eye disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease, also known as Graves' ophthalmopathy. This condition is associated with autoimmune thyroid disease, where the body's immune system mistakenly attacks the tissues around the eyes, leading to inflammation and swelling. This results in the characteristic bulging of the eyes, known as proptosis or exophthalmos.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid eye disease is particularly common in middle-aged individuals and can cause both unilateral (one eye) and bilateral (both eyes) proptosis. The pathophysiology involves the expansion of the extraocular muscles and increased orbital fat, leading to the protrusion of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Soft tissue tumour in orbit</strong>: While soft tissue tumors in the orbit can cause proptosis, they are not the most common cause in middle-aged individuals. These tumors can be benign or malignant and require imaging studies for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Optic nerve meningioma</strong>: This type of tumor is associated with neurofibromatosis type 2 (NF2) and can lead to proptosis. However, it is less common compared to thyroid eye disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Cavernous hemangioma</strong>: Although cavernous hemangioma is the most common orbital tumor in adults, it is not the most common cause of proptosis. These benign vascular tumors can cause proptosis if they become large enough to displace the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of proptosis in a middle-aged person is thyroid eye disease (Graves' ophthalmopathy).</span></p>",
      "correct_choice_id": 216606,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54269,
      "choices": [
        {
          "id": 216545,
          "text": "<p><span style=\"font-size:12.0pt;\">S. glucose &gt; 250 mg/dL</span></p>"
        },
        {
          "id": 216546,
          "text": "<p><span style=\"font-size:12.0pt;\">Arterial pH &lt; 7.3</span></p>"
        },
        {
          "id": 216547,
          "text": "<p><span style=\"font-size:12.0pt;\">Anion gap &gt; 12</span></p>"
        },
        {
          "id": 216548,
          "text": "<p><span style=\"font-size:12.0pt;\">S. Potassium &lt; 3.5 mEq/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are criteria for diagnosis of DKA except:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5186614",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066931,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>&nbsp;Ans. D) S. Potassium &lt; 3.5 mEq/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis (DKA) is a serious complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. The diagnostic criteria for DKA typically include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hyperglycemia:</strong> Blood glucose levels greater than 250 mg/dL.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ketosis:</strong> Presence of ketones in the blood or urine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metabolic Acidosis:</strong> Indicated by an arterial pH of less than 7.3, a serum bicarbonate level of less than 15-18 mEq/L, and an anion gap greater than 12.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>S. Potassium &lt; 3.5 mEq/L</strong> is not a diagnostic criterion for DKA. Although potassium imbalance is common in DKA due to shifts between the intracellular and extracellular compartments, serum potassium levels are not used as a diagnostic criterion. Potassium levels can vary and might be normal, elevated, or decreased, depending on the stage of DKA and the treatment administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. S. glucose &gt; 250 mg/dL:</strong> This is a diagnostic criterion for DKA as it confirms the presence of significant hyperglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Arterial pH &lt; 7.3:</strong> This indicates metabolic acidosis, which is a key component of DKA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anion gap &gt; 12:</strong> An increased anion gap signifies high anion gap metabolic acidosis (HAGMA), which is typical in DKA due to the presence of ketone bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnostic criteria for DKA include hyperglycemia, ketosis, and metabolic acidosis with an increased anion gap. Potassium levels, while important to monitor and manage in DKA, are not part of the diagnostic criteria.</span></p>",
      "correct_choice_id": 216548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57158,
      "choices": [
        {
          "id": 228021,
          "text": "<p><span style=\"font-size:11.0pt;\">HDL levels</span></p>"
        },
        {
          "id": 228022,
          "text": "<p><span style=\"font-size:11.0pt;\">Hip circumference</span></p>"
        },
        {
          "id": 228023,
          "text": "<p><span style=\"font-size:11.0pt;\">Blood glucose</span></p>"
        },
        {
          "id": 228024,
          "text": "<p><span style=\"font-size:11.0pt;\">Blood pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following will not be measured to diagnose metabolic syndrome? (INICET MAY 2023)</span></p>",
      "unique_key": "Q7834727",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066908,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Hip circumference</strong></span></p><p><br><span style=\"font-size:12pt;\">Metabolic syndrome criteria include: HDL levels, Blood glucose, Blood pressure and Waist circumference (NOT hip circumference)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Waist circumference</strong> - more than 102 centimeter in males or more than 88 centimeter in females&nbsp;is one of the important criteria for metabolic syndrome. Central obesity is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option A. HDL levels</strong>: Low HDL levels (&lt;40 mg/dL in males, &lt;50 mg/dL in females) are a criterion for metabolic syndrome.</span></p><p><span style=\"font-size:12.0pt;\">High triglyceride levels (&gt;150 mg/dL) are a criterion for metabolic syndrome.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Blood glucose</strong>: Impaired glucose tolerance or type 2 diabetes is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blood pressure:</strong> BP &gt;140/90 mmHg or being hypertensive is a criterion for metabolic syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Note - </strong>To diagnose metabolic syndrome, the presence of at least three of these criteria is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hip circumference is not used in the diagnosis of metabolic syndrome; instead, waist circumference is measured.</span></p>",
      "correct_choice_id": 228022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11627,
      "choices": [
        {
          "id": 46474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI showing &lt; 1/3rd of MCA territorial infarct</span></span></span></p>"
        },
        {
          "id": 46475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg</span></span></span></p>"
        },
        {
          "id": 46476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ischemia &lt; 2 hours</span></span></span></p>"
        },
        {
          "id": 46477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset of symptoms &lt; 4 hours</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis can be considered in all of these conditions, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q2949716",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066918,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Blood pressure of &gt; 185/110 mmHg</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood pressure of &gt; 185/110 mmHg: This is a contraindication for thrombolysis. Elevated blood pressure increases the risk of hemorrhagic complications during thrombolysis. Therefore, blood pressure must be controlled to below 185/110 mmHg before initiating thrombolytic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is a treatment used to dissolve blood clots in certain types of stroke patients. It is most effective when administered within a specific time window from the onset of symptoms and under certain conditions to ensure patient safety and efficacy of the treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. MRI showing &lt; 1/3rd of MCA territorial infarct:</span></strong><span style=\"font-size:12.0pt\"> This indicates that the infarct size is within a range that is generally considered safe for thrombolysis. More extensive infarcts (&gt; 1/3rd of the middle cerebral artery territory) are a contraindication due to the higher risk of hemorrhagic transformation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>C. Ischemia &lt; 2 hours and D. Onset of symptoms &lt; 4 hours</strong>: Both of these options fall within the critical time window for thrombolysis, which is generally considered up to 4.5 hours from symptom onset. Treatment within this time frame can significantly improve outcomes in stroke patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombolysis is contraindicated in patients with blood pressure higher than 185/110 mmHg at the time of treatment.</span></span></span></p>",
      "correct_choice_id": 46475,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24768,
      "choices": [
        {
          "id": 99033,
          "text": "<p><span style=\"font-size:11.0pt;\">TPE removes the von Willebrand factor</span></p>"
        },
        {
          "id": 99034,
          "text": "<p><span style=\"font-size:11.0pt;\">TPE removes the antiplatelet antibodies</span></p>"
        },
        {
          "id": 99035,
          "text": "<p><span style=\"font-size:11.0pt;\">TPE replenishes the coagulation factors</span></p>"
        },
        {
          "id": 99036,
          "text": "<p><span style=\"font-size:11.0pt;\">TPE removes anti-ADAMTS13 autoantibodies and thereby increases ADAMTS protease activity</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Total plasma exchange is done in thrombotic thrombocytopenic purpura. How does TPE help in the management of TTP? (INICET MAY 2023)</span></p>",
      "unique_key": "Q1809661",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066899,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;TPE removes anti-ADAMTS13 autoantibodies and thereby increases ADAMTS protease activity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thrombotic thrombocytopenic purpura (TTP) is caused by a deficiency of ADAMTS13, usually due to autoantibodies. Total plasma exchange (TPE) removes these autoantibodies, thereby increasing ADAMTS13 protease activity and preventing the accumulation of large von Willebrand factor multimers. This results in platelet trapping. Classic clinical picture includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Microangiopathic hemolytic anemia (MAHA)</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">End-organ damage (neurological injury)</span></li><li><span style=\"font-size:12.0pt;\">Fever</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. TPE removes the von Willebrand factor</strong>: Incorrect; the goal is to remove autoantibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. TPE removes the antiplatelet antibodies:</strong> Incorrect; TTP involves anti-ADAMTS13 autoantibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. TPE replenishes the coagulation factors:</strong> Incorrect; TTP is not primarily a coagulation factor deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TPE in TTP primarily removes anti-ADAMTS13 autoantibodies, increasing ADAMTS13 activity and reducing microthrombi formation.</span></p>",
      "correct_choice_id": 99036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24774,
      "choices": [
        {
          "id": 99057,
          "text": "<p><span style=\"font-size:11.0pt;\">Obesity hypoventilation syndrome</span></p>"
        },
        {
          "id": 99058,
          "text": "<p><span style=\"font-size:11.0pt;\">Obstructive sleep apnea</span></p>"
        },
        {
          "id": 99059,
          "text": "<p><span style=\"font-size:11.0pt;\">Central sleep apnea</span></p>"
        },
        {
          "id": 99060,
          "text": "<p><span style=\"font-size:11.0pt;\">Narcolepsy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A female presented with excessive daytime sleepiness and impaired concentration and memory for one year. On examination the BMI was 43 kg/m² and BP was 170/98 mmHg. ABG was done in awake state and the findings are given below. Which of the following is the likely diagnosis? PaO2: 70 mmHg PaCO2: 53 mmHg HCO3: 33 mmHg. (INICET MAY 2023)</span></p>",
      "unique_key": "Q9899699",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066905,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Obesity hypoventilation syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Obesity hypoventilation syndrome (OHS), </strong>also known as Pickwickian syndrome, is characterized by obesity (BMI &gt;30 kg/m²), hypoventilation (PaCO2 &gt;45 mmHg), and lack of significant underlying lung disease. The ABG findings showing hypercapnia (high PaCO2) and hypoxemia (low PaO2) in the awake state are indicative of OHS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Obstructive sleep apnea:</strong> Occurs during sleep, not necessarily presenting with hypercapnia in the awake state.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Central sleep apnea:</strong> Characterized by pauses in breathing during sleep without the obesity-related hypoventilation.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Narcolepsy:</strong> Does not typically present with ABG abnormalities or obesity hypoventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obesity hypoventilation syndrome involves obesity, chronic hypercapnia, and hypoxemia, primarily in the awake state.</span></p>",
      "correct_choice_id": 99057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54268,
      "choices": [
        {
          "id": 216541,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercortisolism</span></span></p>"
        },
        {
          "id": 216542,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperthyroidism</span></span></p>"
        },
        {
          "id": 216543,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperparathyroidism</span></span></p>"
        },
        {
          "id": 216544,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperaldosteronism</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old man presented with weight gain, proximal muscle weakness, purple striae, and easy bruising. What is the likely underlying condition?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3026143",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066930,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hypercortisolism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypercortisolism, also known as Cushing&#39;s syndrome, is characterized by an excess of cortisol in the body. The clinical features of Cushing&#39;s syndrome include weight gain, particularly in the face, neck, and trunk, proximal muscle weakness, purple striae (stretch marks), and easy bruising. These symptoms are a result of the catabolic effects of cortisol on various tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight Gain:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Cortisol promotes the deposition of fat in specific areas, leading to central obesity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proximal Muscle Weakness:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Cortisol has catabolic effects on muscle tissue, leading to muscle wasting and weakness, particularly in the proximal muscles.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Purple Striae:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Cortisol weakens the skin by breaking down collagen, leading to the formation of purple striae.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Easy Bruising:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Cortisol reduces the ability of blood vessels to repair themselves, causing increased bruising.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Hyperthyroidism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition involves an excess of thyroid hormones, leading to symptoms such as weight loss, increased appetite, heat intolerance, and hyperactivity. It does not typically cause the symptoms described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Hyperparathyroidism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition involves an excess of parathyroid hormone, leading to hypercalcemia, bone pain, kidney stones, and abdominal pain. It does not cause the symptoms described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hyperaldosteronism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition involves an excess of aldosterone, leading to hypertension and hypokalemia. It does not cause the symptoms described in the question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s syndrome, or hypercortisolism, is characterized by weight gain, proximal muscle weakness, purple striae, and easy bruising due to the catabolic effects of excess cortisol.</span></span></p>",
      "correct_choice_id": 216541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24769,
      "choices": [
        {
          "id": 99037,
          "text": "<p><span style=\"font-size:11.0pt;\">Babinski sign</span></p>"
        },
        {
          "id": 99038,
          "text": "<p><span style=\"font-size:11.0pt;\">Ankle jerk</span></p>"
        },
        {
          "id": 99039,
          "text": "<p><span style=\"font-size:11.0pt;\">Jendrassik</span></p>"
        },
        {
          "id": 99040,
          "text": "<p><span style=\"font-size:11.0pt;\">Normal plantar response</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the sign? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-134049.png\" alt=\"\" width=\"300\" height=\"183\"></span></p>",
      "unique_key": "Q8767494",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066900,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Babinski sign</strong></span></p><p><br><span style=\"font-size:12pt;\">The Babinski sign is a reflex response where the big toe extends upward and the other toes fan out upon stimulation of the sole. This indicates an upper motor neuron lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ankle jerk:</strong> Reflex action at the ankle joint.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Jendrassik:</strong> Maneuver to enhance reflexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Normal plantar response:</strong> Flexion of all toes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A positive Babinski sign indicates an upper motor neuron lesion.</span></p>",
      "correct_choice_id": 99037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54259,
      "choices": [
        {
          "id": 216505,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compressions at 100-120/min</span></p>"
        },
        {
          "id": 216506,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow adequate chest recoil</span></p>"
        },
        {
          "id": 216507,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compression to Rescue breath ratio is 30:2</span></p>"
        },
        {
          "id": 216508,
          "text": "<p><span style=\"font-size:12.0pt;\">Depth of compression must be 3-4cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Which of the following is incorrect regarding High-Quality CPR?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8354104",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066921,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Depth of compression must be 3-4cm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement \"Depth of compression must be 3-4cm\" is incorrect for high-quality CPR. The correct depth of chest compression for adults is approximately <strong>5 centimeters (or 2 inches). </strong>This depth ensures adequate blood flow during cardiopulmonary resuscitation. The 3-4cm depth mentioned in the option is insufficient for effective CPR in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chest compressions at 100-120/min:</strong> This is correct. The recommended rate for chest compressions during CPR is 100-120 compressions per minute. This rate optimizes blood flow during resuscitation efforts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Allow adequate chest recoil:</strong> This statement is correct. Allowing full chest recoil between compressions is crucial for effective CPR. It enables proper diastolic filling of the heart, improving overall circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chest compression to Rescue breath ratio is 30:2:</strong> This is also correct. For adult CPR without an advanced airway, the standard ratio is 30 chest compressions followed by 2 rescue breaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-quality CPR for adults, the correct depth of chest compressions is approximately 5 centimeters (2 inches), not 3-4cm as stated in the incorrect option.</span></p>",
      "correct_choice_id": 216508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24763,
      "choices": [
        {
          "id": 99013,
          "text": "<p><span style=\"font-size:11.0pt;\">2, 4 only</span></p>"
        },
        {
          "id": 99014,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 3 only</span></p>"
        },
        {
          "id": 99015,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 2 ,3,4</span></p>"
        },
        {
          "id": 99016,
          "text": "<p><span style=\"font-size:11.0pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe vomiting and diarrhea and has orthostatic hypotension. What metabolic abnormalities would you expect in this patient? (INICET MAY 2023)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1.Hypokalemia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2.Hypochloremia</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3.Metabolic alkalosis</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4.Respiratory alkalosis</span></p>",
      "unique_key": "Q8200355",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066894,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;1, 2, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe vomiting and diarrhea can lead to multiple metabolic abnormalities: Hypokalemia, Hypochloremia, metabolic alkalosis with hyponatremia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. <strong>Hypokalemia</strong>: Loss of potassium through vomiting and diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2. <strong>Hypochloremia</strong>: Loss of chloride.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">3.<strong> Metabolic alkalosis</strong>: Loss of gastric acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These changes are due to the loss of electrolytes and fluids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">4. <strong>Respiratory alkalosis </strong>involves hyperventilation and a decrease in carbon dioxide, which is unrelated to the described condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe vomiting and diarrhea typically cause hypokalemia, hypochloremia, and metabolic alkalosis.</span></p>",
      "correct_choice_id": 99016,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54296,
      "choices": [
        {
          "id": 216653,
          "text": "<p><span style=\"font-size:12.0pt;\">Purulent conjunctivitis</span></p>"
        },
        {
          "id": 216654,
          "text": "<p><span style=\"font-size:12.0pt;\">Rash</span></p>"
        },
        {
          "id": 216655,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymphadenopathy</span></p>"
        },
        {
          "id": 216656,
          "text": "<p><span style=\"font-size:12.0pt;\">Strawberry tongue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one is not a criterion for Kawasaki disease?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1092164",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066881,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Purulent conjunctivitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Purulent conjunctivitis</strong> is not a criterion for Kawasaki disease. Instead, the conjunctivitis seen in Kawasaki disease is non-purulent and sterile, meaning it does not produce pus, and cultures are negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kawasaki disease is an acute, self-limited vasculitis that predominantly affects children. The diagnostic criteria for Kawasaki disease include the presence of fever for at least five days, along with at least four of the following five clinical features:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Bilateral non-purulent conjunctival injection (conjunctivitis):</strong> This is a common feature in Kawasaki disease, but it is non-purulent (does not produce pus).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Changes in the lips and oral cavity:</strong> This includes strawberry tongue (a red, bumpy tongue), erythema, and cracking of the lips.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Polymorphous rash:</strong> A rash of various forms can be present.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cervical lymphadenopathy:</strong> Typically unilateral and larger than 1.5 cm in diameter.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Changes in the extremities:</strong> This includes erythema of the palms and soles, edema of the hands and feet, and later desquamation (peeling) of the skin.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>TOC - IVIG (Intravenous Immunoglobulin) ±</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Aspirin</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rash:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">A polymorphous rash is one of the key diagnostic criteria for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lymphadenopathy:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Cervical lymphadenopathy is another diagnostic criterion, usually unilateral and larger than 1.5 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Strawberry tongue:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Changes in the lips and oral cavity, including strawberry tongue, are diagnostic criteria for Kawasaki disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kawasaki disease is diagnosed based on a set of clinical criteria, including non-purulent conjunctivitis, rash, lymphadenopathy, and changes in the oral cavity such as strawberry tongue. Purulent conjunctivitis is not a feature of Kawasaki disease.</span></p>",
      "correct_choice_id": 216653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54294,
      "choices": [
        {
          "id": 216645,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Occur in the early 20s, rare after 40</span></span></span></p>"
        },
        {
          "id": 216646,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More common in males than females </span></span></span></p>"
        },
        {
          "id": 216647,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HLA B27 is positive in &gt;90%</span></span></span></p>"
        },
        {
          "id": 216648,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRI shows non-erosive joint widening</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the following statements regarding Ankylosing Spondylitis are true except:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3620221",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066879,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) MRI shows non-erosive joint widening</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRI shows non-erosive joint widening</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is false. In ankylosing spondylitis, MRI typically shows evidence <strong>of erosions, joint narrowing, and inflammatory changes</strong> in the sacroiliac joints and spine. The disease can lead to ankylosis (fusion of the spine), syndesmophytes, and erosive arthropathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints. The correct statements regarding AS are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Occur in the early 20s, rare after 40</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ankylosing spondylitis typically presents in young adults, often in their 20s, and is uncommon after the age of 40.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. More common in males than females</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: AS is more prevalent in males, with a male-to-female ratio of approximately 3:1.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. HLA B27 is positive in &gt;90%</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Over 90% of patients with AS test positive for the HLA-B27 gene, which is a significant marker for the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRI findings in ankylosing spondylitis typically show erosive changes and joint narrowing, not non-erosive joint widening.</span></span></span></p>",
      "correct_choice_id": 216648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24780,
      "choices": [
        {
          "id": 99081,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
        },
        {
          "id": 99082,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2</span></p>"
        },
        {
          "id": 99083,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4</span></p>"
        },
        {
          "id": 99084,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female with nephrotic syndrome underwent a renal biopsy. Which of the following statements is correct? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">FSGS cannot be diagnosed by a percutaneous renal biopsy</span></li><li><span style=\"font-size:12.0pt;\">Patient should be observed for 24 hours following biopsy</span></li><li><span style=\"font-size:12.0pt;\">Dark red clots in the urine following a biopsy indicate a hematoma</span></li><li><span style=\"font-size:12.0pt;\">Patients with features of systemic amyloidosis and renal involvement can undergo abdominal fat pad biopsy instead of renal biopsy</span></li></ol>",
      "unique_key": "Q1461879",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066911,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2,3,4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following a renal biopsy, it is crucial to monitor the patient for potential complications, including bleeding and hematoma formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Observation post-biopsy:</strong> Patients should be observed for 24 hours following a renal biopsy to monitor for complications such as bleeding or infection.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Dark red clots in urine: </strong>Dark red clots in the urine following a biopsy can indicate a hematoma. This is a potential complication that needs to be monitored.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Abdominal fat pad biopsy:</strong> Patients with systemic amyloidosis and renal involvement can undergo an abdominal fat pad biopsy as an alternative to a renal biopsy. This method can help diagnose systemic amyloidosis with less risk compared to a renal biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. FSGS cannot be diagnosed by a percutaneous renal biopsy</strong>: This statement is incorrect. Focal segmental glomerulosclerosis (FSGS) can indeed be diagnosed by a percutaneous renal biopsy. The biopsy helps in identifying the characteristic histological changes associated with FSGS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-biopsy observation, recognition of biopsy-related complications, and alternative biopsy methods for systemic amyloidosis are essential in nephrotic syndrome management.</span></p>",
      "correct_choice_id": 99084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54287,
      "choices": [
        {
          "id": 216617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ventricular tachycardia</span></span></span></p>"
        },
        {
          "id": 216618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quadriparesis</span></span></span></p>"
        },
        {
          "id": 216619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diabetes insipidus</span></span></span></p>"
        },
        {
          "id": 216620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old man was admitted to the hospital after three days of abdominal pain and vomiting. His laboratory reports revealed a potassium value of 3.2 mEq/L. All of the following can be seen except:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8906926",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066872,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Cerebral edema</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient has hypokalemia, indicated by a potassium level of 3.2 mEq/L. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is not seen with </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema</span></strong><span style=\"font-size:12.0pt\">, which </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is typically associated with hyponatremia (low sodium levels) rather than hypokalemia. Hyponatremia can lead to an osmotic imbalance, causing water to move into brain cells and resulting in cerebral edema. This is not a recognized complication of hypokalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypokalemia can lead to several clinical manifestations:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ventricular tachycardia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hypokalemia can cause ventricular arrhythmias, including ventricular tachycardia, due to its effect on cardiac electrical activity. Potassium is crucial for maintaining normal heart rhythm, and its deficiency can lead to dangerous arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quadriparesis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hypokalemia can cause muscle weakness and paralysis, including quadriparesis. It affects muscle function because potassium is essential for normal muscle cell function and nerve transmission. Severe hypokalemia can mimic conditions like Guillain-Barr&eacute; syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diabetes insipidus:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hypokalemia can cause nephrogenic diabetes insipidus. This condition occurs due to a defect in the kidney&#39;s ability to respond to antidiuretic hormone (ADH), leading to excessive urination and thirst. Hypokalemia impairs the kidney&#39;s concentrating ability, contributing to this disorder.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cerebral edema is not associated with hypokalemia; it is a complication of hyponatremia. Hypokalemia can cause ventricular arrhythmias, muscle weakness, and nephrogenic diabetes insipidus.</span></span></span></p>",
      "correct_choice_id": 216620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24762,
      "choices": [
        {
          "id": 99009,
          "text": "<p><span style=\"font-size:11.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 99010,
          "text": "<p><span style=\"font-size:11.0pt;\">Ceftriaxone plus azithromycin</span></p>"
        },
        {
          "id": 99011,
          "text": "<p><span style=\"font-size:11.0pt;\">Amoxicillin plus clavulanic acid</span></p>"
        },
        {
          "id": 99012,
          "text": "<p><span style=\"font-size:11.0pt;\">Piperacillin Tazobactam plus ciprofloxacin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A patient in emergency has the following lab parameters: creatinine 1.5 and BUN 45. The chest x-ray is shown below. In gram staining and culture only, rhinovirus was isolated. The patient is shifted to ICU. What is the treatment of choice in this patient? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am_uLaNUaB.jpeg\" alt=\"\" width=\"300\" height=\"212\"></span></p>",
      "unique_key": "Q9499007",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066893,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B)&nbsp;Ceftriaxone plus azithromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient is diagnosed with <strong>community-acquired pneumonia (CAP)</strong> and has been shifted to the ICU. The treatment of choice for ICU-admitted patients with CAP includes a <strong>beta-lactam antibiotic</strong> like beta-lactam/beta-lactamase inhibitor (BL/BLI) combination like amoxicillin-clavulanic acid or piperacillin-tazobactam, or a third-generation cephalosporin like ceftriaxone combined with azithromycin or a respiratory fluoroquinolone such as levofloxacin or moxifloxacin should be administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ceftriaxone are used to cover typical bacteria, while azithromycin covers atypical bacteria and provides additional anti-inflammatory properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Azithromycin</strong>: Insufficient as monotherapy in ICU settings.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amoxicillin plus clavulanic acid:</strong> Lacks coverage for atypical pathogens alone.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Piperacillin Tazobactam plus ciprofloxacin</strong>: Ciprofloxacin is not a respiratory fluoroquinolone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The combination of a beta-lactam antibiotic and azithromycin is the treatment of choice for ICU-admitted patients with community-acquired pneumonia.</span></p>",
      "correct_choice_id": 99010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54289,
      "choices": [
        {
          "id": 216625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-Anion Gap Metabolic Acidosis (NAGMA)</span></span></span></p>"
        },
        {
          "id": 216626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High Anion Gap Metabolic Acidosis (HAGMA)</span></span></span></p>"
        },
        {
          "id": 216627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Compensated Metabolic Alkalosis</span></span></span></p>"
        },
        {
          "id": 216628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory Acidosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient arrives at the emergency department presenting with symptoms of abdominal pain, vomiting, tachypnea, and tachycardia. Laboratory results are as follows: pH: 7.34, Sodium: 135 mmol/L, Potassium: 5 mmol/L, Bicarbonate: 12 mmol/L, Chloride: 92 mmol/L, RBS: 450 mg/dL. Given these laboratory findings, which of the following statements best describes the patient&#39;s acid-base status?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3295743",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066874,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) High Anion Gap Metabolic Acidosis (HAGMA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&#39;s clinical presentation and laboratory findings suggest diabetic ketoacidosis (DKA), a condition commonly seen in diabetes patients with high blood sugar levels (RBS: 450 mg/dL). The symptoms of abdominal pain, vomiting, tachypnea (rapid breathing), and tachycardia (rapid heart rate) are characteristic of DKA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The laboratory values indicate a metabolic acidosis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pH of 7.34</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Slightly acidic, indicating acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bicarbonate of 12 mmol/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Low, consistent with metabolic acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloride of 92 mmol/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Lower than normal.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To determine the type of metabolic acidosis, we calculate the anion gap: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-125329.jpg\" style=\"height:66px; width:900px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An anion gap greater than 12 mmol/L indicates a high anion gap metabolic acidosis (HAGMA). In this case, the anion gap is 31, confirming HAGMA.&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High anion gap metabolic acidosis is typically associated with conditions such as diabetic ketoacidosis, lactic acidosis, renal failure, and ingestion of toxins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Non-Anion Gap Metabolic Acidosis (NAGMA)</strong>: This occurs when the anion gap is normal (less than 12 mmol/L). Conditions that cause NAGMA include diarrhea and renal tubular acidosis. This does not match the patient&#39;s high anion gap.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Compensated Metabolic Alkalosis</strong>: This condition involves an elevated pH with high bicarbonate levels. The patient&rsquo;s pH is acidic, not alkalotic, and bicarbonate is low.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Respiratory Acidosis</strong>: Characterized by a primary increase in carbon dioxide (CO2) levels leading to a low pH. The patient&rsquo;s primary disturbance is metabolic, not respiratory.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by an anion gap greater than 12 mmol/L, indicating an accumulation of unmeasured anions. This condition is often seen in diabetic ketoacidosis, which presents with elevated blood glucose levels and metabolic acidosis.</span></span></p>",
      "correct_choice_id": 216626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54264,
      "choices": [
        {
          "id": 216525,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos Syndrome</span></p>"
        },
        {
          "id": 216526,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan's Syndrome</span></p>"
        },
        {
          "id": 216527,
          "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerosis</span></p>"
        },
        {
          "id": 216528,
          "text": "<p><span style=\"font-size:12.0pt;\">Scurvy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following connective tissue degradation disorder is associated with aortic aneurysm?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1616423",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066926,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Marfan's Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder that affects the body's connective tissues, which provide structural support to various organs and tissues. It is particularly associated with cardiovascular complications, including aortic aneurysms and dissections. This is due to the weakening of the aortic wall caused by defective fibrillin-1, a glycoprotein essential for the elasticity and strength of the connective tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Ehlers-Danlos Syndrome</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">While Ehlers-Danlos Syndrome (EDS) can lead to vascular complications, including aortic aneurysms, it is specifically the vascular type (Type IV) of EDS that is associated with these issues. However, Marfan's Syndrome is more commonly linked to aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Atherosclerosis</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Atherosclerosis is a condition characterized by the build-up of plaque within the arterial walls, leading to narrowing and hardening of the arteries. It is a risk factor for abdominal aortic aneurysm but is not classified as a connective tissue disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Scurvy</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Scurvy is caused by a deficiency in vitamin C, leading to defective collagen synthesis. While it results in symptoms like mucosal bleeding and poor wound healing, it is not associated with aortic aneurysms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marfan's Syndrome is a connective tissue disorder closely associated with the development of aortic aneurysms due to the defective fibrillin-1 protein affecting the structural integrity of the aortic wall.</span></p>",
      "correct_choice_id": 216526,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54303,
      "choices": [
        {
          "id": 216681,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adduction</span></span></span></p>"
        },
        {
          "id": 216682,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abduction</span></span></span></p>"
        },
        {
          "id": 216683,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depression</span></span></span></p>"
        },
        {
          "id": 216684,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intorsion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;All of the following are functions of the superior oblique except:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8278160",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066888,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A) Adduction</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adduction</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not a function of the superior oblique muscle. Adduction involves moving the eyeball towards the midline (towards the nose), and this movement is primarily mediated by the medial rectus muscle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abduction:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The superior oblique muscle helps in the lateral movement of the eyeball, meaning it moves the eye away from the midline (abduction).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depression:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> When the eye is adducted (turned towards the nose), the superior oblique muscle helps to depress the eyeball, moving it downward.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intorsion:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the primary function of the superior oblique muscle. Intorsion involves the rotation of the top of the eyeball towards the nose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The superior oblique muscle is one of the extraocular muscles and is innervated by the trochlear nerve (cranial nerve IV). The primary functions of the superior oblique muscle can be remembered using the mnemonic &quot;SO-LID&quot;:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">uperior <strong>O</strong>blique</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ateral movement (Abduction)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ntorsion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">epression</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 216681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54293,
      "choices": [
        {
          "id": 216641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arthritis</span></span></span></p>"
        },
        {
          "id": 216642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GI bleeding</span></span></span></p>"
        },
        {
          "id": 216643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal pain</span></span></span></p>"
        },
        {
          "id": 216644,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Skin rash</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following in IgA vasculitis warrants the use of corticosteroids?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7861595",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066883,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) GI bleeding</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IgA vasculitis, also known as Henoch-Sch&ouml;nlein purpura, typically presents with symptoms such as arthritis, abdominal pain, and skin rash. These symptoms are often managed with supportive care and nonsteroidal anti-inflammatory drugs (NSAIDs). However, the use of corticosteroids is reserved for more severe manifestations of the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GI bleeding</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In cases where IgA vasculitis leads to gastrointestinal bleeding, corticosteroids are warranted. This is because GI bleeding indicates a severe form of the disease involving the gastrointestinal tract, which requires more aggressive treatment to reduce inflammation and prevent further complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Arthritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Joint pain and swelling associated with IgA vasculitis are usually mild and managed with NSAIDs or supportive care. Corticosteroids are not typically indicated for arthritis alone in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Abdominal pain</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Abdominal pain in IgA vasculitis can often be managed with supportive care and NSAIDs. Corticosteroids are reserved for severe cases or when there is evidence of significant gastrointestinal involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Skin rash</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The characteristic purpuric rash of IgA vasculitis is usually self-limiting and does not require corticosteroids for treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are indicated in IgA vasculitis primarily for severe manifestations such as gastrointestinal bleeding, indicating more extensive disease involvement.</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other manifestations, such as arthritis, abdominal pain, and skin rash, are generally self-limiting and respond well to supportive care. Corticosteroids are not typically required for these symptoms unless they are part of a more severe systemic involvement.</span></span></span></p>",
      "correct_choice_id": 216642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24771,
      "choices": [
        {
          "id": 99045,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 99046,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
        },
        {
          "id": 99047,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 99048,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following are seen in iron deficiency anemia? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1.Reduced serum iron level</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">2.Reduced transferrin saturation</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">3.Increased total iron binding capacity</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4.Reduced ferritin level</span></p>",
      "unique_key": "Q1725094",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066902,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2, 3, 4</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Iron deficiency anemia (IDA) is characterized by reduced ferritin, which is the one of the first indicators of IDA, ferritin indicates the iron stores in the body. Serum iron levels will drop after ferritin levels decrease. Total iron binding capacity (TIBC) will increase. Transferrin saturation, a measure of iron and TIBC, will reduce. Transferrin saturation is less than 18%, but less than 20% indicates iron deficiency anemia.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Reduced serum iron level: Low iron levels in the blood.</span></li><li><span style=\"font-size:12.0pt;\">Reduced transferrin saturation: Less iron available for transport.</span></li><li><span style=\"font-size:12.0pt;\">Increased total iron binding capacity (TIBC): The body produces more transferrin to capture iron.</span></li><li><span style=\"font-size:12.0pt;\">Reduced ferritin level: Indicates low iron stores.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia involves reduced serum iron, reduced transferrin saturation, increased TIBC, and reduced ferritin levels</span></p>",
      "correct_choice_id": 99047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54267,
      "choices": [
        {
          "id": 216537,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 216538,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 2 and 4</span></p>"
        },
        {
          "id": 216539,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4 and 2</span></p>"
        },
        {
          "id": 216540,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 2, 1 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Many GPCR receptors act via an increase in cAMP. The steps involved in this mechanism are given below. Which of the following is the correct sequence of events in the cAMP signal transduction pathway?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12.0pt;\">Activation of PKA</span></li><li><span style=\"font-size:12.0pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12.0pt;\">Phosphorylation of target proteins</span></li></ol>",
      "unique_key": "Q3165755",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G protein-coupled receptors (GPCRs) that act via an increase in cyclic AMP (cAMP) follow a specific sequence of events in the signal transduction pathway. The steps involved are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Activation of Adenylate Cyclase:</strong> Upon ligand binding to the G-stimulatory GPCR, the receptor activates adenylate cyclase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Conversion of ATP to cAMP:</strong> The activated adenylate cyclase converts ATP to cyclic AMP (cAMP).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Activation of Protein Kinase A (PKA):</strong> The increased levels of cAMP activate protein kinase A (PKA).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Phosphorylation of Target Proteins:</strong> PKA then phosphorylates various target proteins, leading to the desired cellular response.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sequence of events accurately describes the cAMP signal transduction pathway activated by G-stimulatory GPCRs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of events in the cAMP signal transduction pathway activated by G-stimulatory GPCRs is: Activation of adenylate cyclase, conversion of ATP to cAMP, activation of PKA, and phosphorylation of target proteins.</span></p>",
      "correct_choice_id": 216538,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54281,
      "choices": [
        {
          "id": 216593,
          "text": "<p><span style=\"font-size:12.0pt;\">ApoE</span></p>"
        },
        {
          "id": 216594,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;ApoCII</span></p>"
        },
        {
          "id": 216595,
          "text": "<p><span style=\"font-size:12.0pt;\">LDLr</span></p>"
        },
        {
          "id": 216596,
          "text": "<p><span style=\"font-size:12.0pt;\">ApoB48</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which gene defect causes familial hyperlipidemia?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7289512",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066866,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) LDLr</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial hyperlipidemia, particularly familial hypercholesterolemia (FH), is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol in the blood. The primary cause of this condition is mutations in the LDL receptor (LDLr) gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong> The LDL receptor is responsible for the uptake of LDL cholesterol from the blood into the liver. When there are mutations in the LDLr gene, the receptors are either dysfunctional or deficient. As a result, LDL cholesterol cannot be effectively removed from the bloodstream, leading to elevated levels of LDL cholesterol. This condition significantly increases the risk of atherosclerosis and cardiovascular diseases.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Heterozygous FH:</strong> This form is more common and results in moderately high LDL cholesterol levels (200-300 mg/dL). It is associated with an increased risk of cardiovascular diseases.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Homozygous FH:</strong> This form is rarer and more severe, with LDL cholesterol levels potentially reaching 600-700 mg/dL. Individuals with homozygous FH have a very high risk of early cardiovascular events and death.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ApoE:</strong></span><span style=\"font-size:11pt;\"><strong> &nbsp;</strong></span><span style=\"font-size:12.0pt;\">Mutations in the ApoE gene cause familial dysbetalipoproteinemia (Type III hyperlipoproteinemia in Frederickson classification), which leads to elevated levels of intermediate-density lipoproteins (IDL) and is characterized by the presence of remnant particles in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ApoCII:</strong></span><span style=\"font-size:11pt;\"><strong> &nbsp;</strong></span><span style=\"font-size:12.0pt;\">Deficiency in ApoCII causes familial chylomicronemia syndrome (Type I hyperlipoproteinemia in Frederickson classification). This condition is associated with extremely high levels of triglycerides due to impaired lipoprotein lipase (LPL) activation, which is necessary for the breakdown of triglycerides.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. ApoB48:</strong></span><span style=\"font-size:11pt;\"><strong> &nbsp;</strong></span><span style=\"font-size:12.0pt;\">ApoB48 is involved in the assembly and secretion of chylomicrons from the intestine. There is no known condition caused by a deficiency of ApoB48 that leads to familial hyperlipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mutations in the LDL receptor (LDLr) gene cause familial hypercholesterolemia, a condition characterized by high levels of LDL cholesterol in the blood due to impaired clearance by the liver. This condition significantly increases the risk of cardiovascular diseases.</span></p>",
      "correct_choice_id": 216595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54288,
      "choices": [
        {
          "id": 216621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory Acidosis</span></span></span></p>"
        },
        {
          "id": 216622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory Alkalosis</span></span></span></p>"
        },
        {
          "id": 216623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metabolic Acidosis</span></span></span></p>"
        },
        {
          "id": 216624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metabolic Alkalosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 35-year-old male presents to the clinic with complaints of nausea, diarrhea, and vomiting. Upon further investigation, arterial blood gas (ABG) analysis reveals the following: pH: 7.55, PCO2: 50 mmHg, HCO3-: 44 mmol/L. Given these findings, which of the following conditions is the most likely diagnosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7762794",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066873,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Metabolic Alkalosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The ABG analysis reveals a pH of 7.55, indicating alkalosis (normal pH range: 7.35-7.45). The elevated bicarbonate (HCO3-) level of 44 mmol/L (normal range: 22-28 mmol/L) points towards a metabolic origin for the alkalosis. In metabolic alkalosis, the kidneys retain bicarbonate, leading to an increase in serum bicarbonate levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additionally, the elevated PCO2 (partial pressure of carbon dioxide) of 50 mmHg (normal range: 35-45 mmHg) indicates a compensatory respiratory response. In metabolic alkalosis, the body attempts to compensate by hypoventilation, which increases PCO2 to counteract the rise in pH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pH 7.55</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Indicates alkalosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PCO2 50 mmHg</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Elevated, indicating respiratory compensation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HCO3- 44 mmol/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Elevated, indicating a metabolic cause.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Respiratory Acidosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition is characterized by a low pH and high PCO2 due to impaired ventilation, resulting in CO2 retention. The pH would be acidic, not alkalotic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Respiratory Alkalosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves a high pH and low PCO2 due to hyperventilation. However, in this case, PCO2 is elevated, not decreased.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Metabolic Acidosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves a low pH and low bicarbonate levels due to an accumulation of acid or loss of bicarbonate. The pH here is alkalotic, not acidic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic alkalosis is characterized by an elevated pH and bicarbonate level, with respiratory compensation leading to increased PCO2.</span></span></p>",
      "correct_choice_id": 216624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54290,
      "choices": [
        {
          "id": 216629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fanconi syndrome presents with RTA 2</span></span></span></p>"
        },
        {
          "id": 216630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bicarbonaturia is a feature of RTA 2</span></span></span></p>"
        },
        {
          "id": 216631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA 4 is associated with hypokalemia</span></span></span></p>"
        },
        {
          "id": 216632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA 4 is due to aldosterone resistance</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Choose the incorrect statement about Renal Tubular Acidosis (RTA):</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7060886",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066875,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) RTA 4 is associated with hypokalemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Renal Tubular Acidosis (RTA) refers to a group of disorders characterized by defective renal acid-base regulation, leading to a normal anion gap metabolic acidosis. The main types of RTA include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 1 (Distal RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Characterized by a defect in the distal tubule&#39;s ability to secrete hydrogen ions, leading to acidosis and hypokalemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 2 (Proximal RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Involves a defect in bicarbonate reabsorption in the proximal tubule, resulting in bicarbonaturia. Fanconi syndrome, a condition involving generalized proximal tubular dysfunction, often presents with RTA Type 2.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 4 (Hyperkalemic RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This type is associated with hypoaldosteronism or aldosterone resistance, leading to impaired potassium excretion and hyperkalemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Fanconi syndrome presents with RTA 2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Fanconi syndrome often involves proximal RTA (Type 2), with features such as aminoaciduria, phosphaturia, glycosuria, and bicarbonaturia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Bicarbonaturia is a feature of RTA 2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Due to defective bicarbonate reabsorption in the proximal tubule, bicarbonaturia is a hallmark of Type 2 RTA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. RTA 4 is due to aldosterone resistance:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Type 4 RTA is commonly due to aldosterone deficiency or resistance, leading to hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RTA Type 4 is characterized by hyperkalemia due to aldosterone deficiency or resistance. The incorrect statement is that RTA Type 4 is associated with hypokalemia, which contradicts the typical presentation of hyperkalemia in this type of RTA.</span></span></p>",
      "correct_choice_id": 216631,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54256,
      "choices": [
        {
          "id": 216493,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 216494,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        },
        {
          "id": 216495,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior MI</span></p>"
        },
        {
          "id": 216496,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myocarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presented with chest pain and shortness of breath. An ECG was taken in the emergency and was shown. What is the likely diagnosis?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-101157.jpg\" alt=\"\" width=\"500\" height=\"234\"></span></p>",
      "unique_key": "Q7254253",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066919,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Posterior MI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows classic signs of a posterior myocardial infarction (MI). The characteristic features of posterior MI in<strong> leads V1, V2 and (±) V3 include a</strong> <strong>tall R wave, ST depression, and upright T wave.</strong> These features suggest a mirror image of an infarction in the posterior wall of the left ventricle. While definitive diagnosis of a posterior MI typically involves additional leads (V7, V8, V9), the observed patterns in leads V2 and V3 are indicative of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the provided case, the absence of ST elevation rules out an acute STEMI. NSTEMI and unstable angina can only be differentiated by cardiac biomarkers such as troponins, which are not mentioned here. Acute myocarditis would typically present with non-specific ECG changes and a relevant clinical history, such as a recent viral infection, which is not present in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NSTEMI:</strong>&nbsp; NSTEMI (Non-ST Elevation Myocardial Infarction) can present with similar symptoms but requires positive cardiac troponins for diagnosis. The absence of troponin data makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Unstable Angina: </strong>Unstable angina presents with similar symptoms but without elevation of cardiac biomarkers. As mentioned, differentiating between NSTEMI and unstable angina is not possible without troponin levels, which are not provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Acute Myocarditis:</strong> Acute myocarditis would typically present with a history of viral infection and can show non-specific ECG changes, often including sinus tachycardia. The patient's history and ECG findings do not support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of tall R waves, ST depression, and upright T waves in leads V2 and V3 are indicative of a posterior myocardial infarction.</span></p>",
      "correct_choice_id": 216495,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54298,
      "choices": [
        {
          "id": 216661,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM1</span></span></span></p>"
        },
        {
          "id": 216662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM2</span></span></span></p>"
        },
        {
          "id": 216663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NREM3</span></span></span></p>"
        },
        {
          "id": 216664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">REM</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Identify the stage of sleep based on the EEG shown below:</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-131403.jpg\" style=\"height:246px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q7209268",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066885,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>D) REM</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The EEG provided shows a pattern that mimics an awake state, which is indicative of REM (Rapid Eye Movement) sleep. REM sleep is characterized by specific EEG, EOG (electro-oculogram), and EMG (electromyogram) patterns:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EEG (Electroencephalogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> During REM sleep, the EEG shows low amplitude, mixed frequency activity that resembles the awake state. This is in contrast to the high amplitude, low-frequency waves seen in NREM (Non-Rapid Eye Movement) sleep stages.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EOG (Electro-oculogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The EOG shows rapid eye movements, which are characteristic of REM sleep. These movements are visible as sharp spikes or fluctuations in the EOG tracing.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EMG (Electromyogram):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The EMG shows muscle atonia or paralysis, which is another hallmark of REM sleep. This paralysis prevents the sleeper from acting out their dreams. Only the diaphragm and extraocular muscles remain active during REM sleep.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. NREM1:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is the lightest stage of sleep, characterized by a transition from wakefulness to sleep. The EEG shows a mix of alpha and theta waves, with some slow eye movements, but it does not resemble the awake state as closely as REM sleep does.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. NREM2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This stage is marked by sleep spindles and K-complexes on the EEG. It is a deeper stage of sleep than NREM1 but does not show the rapid eye movements or muscle atonia seen in REM sleep.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. NREM3:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Also known as slow-wave sleep (SWS), this stage is characterized by high amplitude, low-frequency delta waves on the EEG. It is the deepest stage of NREM sleep and does not resemble the awake state.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">REM sleep is characterized by EEG patterns similar to wakefulness, rapid eye movements on EOG, and muscle atonia on EMG.</span></span></span></p>",
      "correct_choice_id": 216664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54300,
      "choices": [
        {
          "id": 216669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coiling</span></span></span></p>"
        },
        {
          "id": 216670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embolization</span></span></span></p>"
        },
        {
          "id": 216671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Basal stent placement</span></span></span></p>"
        },
        {
          "id": 216672,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Balloon Angioplasty</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interventional technique used for the management of cerebral aneurysm:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1145412",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066890,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A) Coiling</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The management of cerebral aneurysms, particularly berry aneurysms, involves two primary interventional techniques: clipping and coiling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coiling</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an endovascular procedure where a catheter is inserted through the femoral artery and navigated to the aneurysm. Coils are then deployed into the aneurysm to induce thrombosis and prevent rupture. Coiling has lower morbidity and mortality rates compared to surgical clipping and is preferred if the aneurysm is accessible for endovascular treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clipping</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This involves a craniotomy where the skull is opened, and a clip is placed at the neck of the aneurysm to isolate it from the circulation. While effective, it is more invasive compared to coiling.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Embolization</strong>: While embolization is used in various vascular interventions, it is not the preferred technique for managing cerebral aneurysms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Basal stent placement</strong>: Stents may be used as an adjunct to coiling to support the coil mass and ensure complete occlusion of the aneurysm, but stent placement alone is not effective for managing aneurysms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Balloon Angioplasty</strong>: This technique is used to dilate narrowed blood vessels but is not suitable for treating aneurysms as it can worsen the aneurysm by increasing the risk of rupture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The preferred interventional technique for the management of cerebral aneurysms is endovascular coiling due to its lower morbidity and mortality compared to surgical clipping.</span></span></p>",
      "correct_choice_id": 216669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InstrumentsBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54266,
      "choices": [
        {
          "id": 216533,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus Nephritis</span></span></p>"
        },
        {
          "id": 216534,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Venous Insufficiency</span></span></p>"
        },
        {
          "id": 216535,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart Failure</span></span></p>"
        },
        {
          "id": 216536,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Liver Disease</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is the least common cause of bipedal edema?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4656874",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Chronic Venous Insufficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic venous insufficiency (CVI) typically leads to asymmetric leg swelling, where one leg is more affected than the other. In cases of CVI, the swelling is often unilateral, and if bilateral, it is usually asymmetric. This makes it the least common cause of bipedal (symmetric) edema among the given options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Lupus Nephritis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition affects the kidneys, leading to fluid retention and typically causing bilateral leg swelling. It is a common cause of symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Heart Failure:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This systemic condition causes the heart to pump blood inefficiently, leading to fluid buildup in the lower extremities and symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Chronic Liver Disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition results in decreased protein synthesis and portal hypertension, causing fluid retention and symmetric bipedal edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic venous insufficiency typically causes unilateral or asymmetric leg swelling, making it the least common cause of symmetric bipedal edema.</span></span></span></p>",
      "correct_choice_id": 216534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54305,
      "choices": [
        {
          "id": 216689,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dravet Syndrome</span></span></span></p>"
        },
        {
          "id": 216690,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lennox-Gastaut Syndrome</span></span></span></p>"
        },
        {
          "id": 216691,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberous Sclerosis</span></span></span></p>"
        },
        {
          "id": 216692,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cannabinoids are approved in all of the following except:</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9409154",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066892,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Rett Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett Syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A rare genetic neurological disorder that primarily affects girls and leads to severe cognitive and physical impairments. While new treatments are being explored, cannabinoids are not currently approved for managing this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cannabinoids, specifically cannabidiol (CBD) formulations such as Epidiolex, have been FDA-approved for use in treating certain epileptic syndromes. These include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dravet Syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A severe form of epilepsy that begins in infancy, characterized by prolonged seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lennox-Gastaut Syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A childhood-onset epilepsy that involves multiple types of seizures and often results in cognitive impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberous Sclerosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A genetic disorder that causes benign tumors to form in many parts of the body, including the brain, which can lead to seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cannabinoids, such as Epidiolex, are approved for the treatment of Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis, but not for Rett Syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Note -</span></strong> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High-dose Epidiolex is an FDA-approved oil formulation of CBD for use as an add-on treatment for Dravet&#39;s and Lennox-Gastaut syndromes and tuberous sclerosis epilepsies. There is clinical evidence for CBD, at lower doses, as an anxiolytic for the treatment of posttraumatic stress, anxiety, and relapse of substance use disorders. Animal studies suggest that this effect of CBD may be mediated by the 5-hydroxytryptamine 1A receptor.</span></span></span></p>",
      "correct_choice_id": 216692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54283,
      "choices": [
        {
          "id": 216601,
          "text": "<p><span style=\"font-size:12.0pt;\">Parafollicular C cells</span></p>"
        },
        {
          "id": 216602,
          "text": "<p><span style=\"font-size:12.0pt;\">Askanazy cells</span></p>"
        },
        {
          "id": 216603,
          "text": "<p><span style=\"font-size:12.0pt;\">Hurthle cells</span></p>"
        },
        {
          "id": 216604,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with neck swelling, compressing the trachea and esophagus. Histopathological assessment shows cell nests and pink extracellular amyloid stroma. What is the cell of origin of this tumor?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6647204",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066868,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Parafollicular C cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of amyloid stroma in the context of a thyroid tumor is indicative of medullary thyroid carcinoma (MTC). Medullary thyroid carcinoma arises from the <strong>parafollicular C cells</strong> of the thyroid gland. These cells are responsible for secreting calcitonin, a hormone involved in calcium homeostasis. The amyloid stroma seen in MTC is due to the deposition of calcitonin-derived polypeptides.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Medullary Thyroid Carcinoma (MTC)</strong>: This is a unique type of thyroid cancer that originates from parafollicular C cells. The hallmark of MTC is the presence of amyloid stroma, which results from calcitonin secretion by these cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The tumor marker for <strong>Papillary Thyroid Carcinoma (PTC)</strong> and <strong>Follicular Thyroid Carcinoma (FTC)</strong> is <strong>thyroglobulin</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The tumor marker for <strong>Medullary Thyroid Carcinoma (MTC)</strong> is <strong>calcitonin</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Askanazy cells</strong>: These cells, also known as Hurthle cells, are large eosinophilic cells found in the thyroid gland but are typically associated with Hurthle cell carcinoma, not medullary thyroid carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hurthle cells</strong>: These cells are a variant of follicular cells and are characteristic of Hurthle cell carcinoma. They do not produce amyloid stroma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Follicular cells</strong>: These cells give rise to other types of thyroid cancers, such as papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC). These tumors do not typically feature amyloid stroma and are more commonly associated with thyroglobulin as a tumor marker, not calcitonin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma is characterized by amyloid stroma and originates from parafollicular C cells of the thyroid gland.</span></p>",
      "correct_choice_id": 216601,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54261,
      "choices": [
        {
          "id": 216513,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true and reason is the correct explanation of assertion</span></span></p>"
        },
        {
          "id": 216514,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true but reason is not the correct explanation of assertion</span></span></p>"
        },
        {
          "id": 216515,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is true, reason is false</span></span></p>"
        },
        {
          "id": 216516,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is false, reason is true</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Assertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Myocarditis is seen as a complication of diphtheria.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Reason</strong>: It is due to bacteremia.&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1669572",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Assertion is true, reason is false</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The assertion that myocarditis is seen as a complication of diphtheria is correct. Myocarditis is a well-known and serious complication of diphtheria, often leading to significant morbidity and mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The reason provided, that myocarditis is due to bacteremia, is incorrect. The complications of diphtheria, including myocarditis, are primarily due to the effects of the diphtheria toxin (toxemia), not bacteremia. The toxin affects various organs, including the heart, leading to myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myocarditis is a complication of diphtheria caused by the diphtheria toxin (toxemia), not by bacteremia.</span></span></span></p>",
      "correct_choice_id": 216515,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54292,
      "choices": [
        {
          "id": 216637,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuretics → Collecting duct</span></p>"
        },
        {
          "id": 216638,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></p>"
        },
        {
          "id": 216639,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides → Loop of Henle</span></p>"
        },
        {
          "id": 216640,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Distal Convoluted tubule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the correct match out of the following diuretics and the respective site of action:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2925626",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066877,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Carbonic Anhydrase inhibitors → Proximal convoluted tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Carbonic Anhydrase inhibitors</strong>: These diuretics inhibit the enzyme carbonic anhydrase, which is located predominantly in the <strong>proximal convoluted tubule.</strong> This inhibition reduces the reabsorption of bicarbonate, sodium, and water in this segment, making \"Carbonic Anhydrase inhibitors → Proximal convoluted tubule\" the correct match.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osmotic diuretics</strong>: These have a diffuse mechanism of action throughout the nephron, primarily affecting water-permeable regions such as the <strong>proximal convoluted tubule and the descending limb of the loop of Henle</strong>. The statement \"Osmotic diuretics → Collecting duct\" is incorrect as the major sites of action are the proximal convoluted tubule and the descending limb, not just the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thiazides</strong>: Thiazide diuretics act on the <strong>distal convoluted tubule</strong> by inhibiting the sodium-chloride transporter. They do not primarily act on the Loop of Henle, making \"Thiazides → Loop of Henle\" incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aldosterone antagonists</strong>: These drugs act on the <strong>collecting ducts</strong>, particularly affecting the principal cells where aldosterone promotes sodium reabsorption and potassium secretion. Therefore, the statement \"Aldosterone antagonists → Distal Convoluted tubule\" is incorrect as their primary site of action is the collecting duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diuretics with their site of action:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osmotic diuretics → Proximal convoluted tubule and the descending limb of the loop of Henle</span></li><li><span style=\"font-size:12.0pt;\">Carbonic Anhydrase inhibitors → Proximal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Thiazides → Distal convoluted tubule</span></li><li><span style=\"font-size:12.0pt;\">Aldosterone antagonists → Collecting duct</span></li></ul>",
      "correct_choice_id": 216638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54272,
      "choices": [
        {
          "id": 216557,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT2 inhibitors</span></span></p>"
        },
        {
          "id": 216558,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finerenone</span></span></p>"
        },
        {
          "id": 216559,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrochlorothiazide</span></span></p>"
        },
        {
          "id": 216560,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiotensin receptor blockers</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old patient with type 2 diabetes mellitus is being evaluated for medications to manage their condition and prevent renal complications. Which of the following drugs will not delay progression of renal disease?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2297921",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066859,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hydrochlorothiazide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide is a thiazide diuretic primarily used to treat hypertension and edema. It is not specifically known to delay the progression of renal disease in patients with type 2 diabetes mellitus. While it helps in managing blood pressure, it does not have the protective renal effects seen with other medications listed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. SGLT2 inhibitors:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These drugs, such as dapagliflozin and empagliflozin, have been shown to provide renal protection by reducing the progression of kidney disease in patients with type 2 diabetes. They work by decreasing glucose reabsorption in the kidneys, leading to osmotic diuresis and reduced glomerular hyperfiltration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Finerenone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a non-steroidal mineralocorticoid receptor antagonist (MRA) approved for the treatment of chronic kidney disease in type 2 diabetes. It helps to reduce albuminuria and slows the progression of renal disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Angiotensin receptor blockers (ARBs):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> ARBs, such as losartan and valsartan, are well-known for their renal protective effects. They help reduce proteinuria and slow the progression of diabetic nephropathy by blocking the effects of angiotensin II on the kidneys.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide does not delay the progression of renal disease in patients with type 2 diabetes. In contrast, SGLT2 inhibitors, finerenone, and angiotensin receptor blockers are all known to provide renal protection and slow the progression of diabetic kidney disease.</span></span></span></p>",
      "correct_choice_id": 216559,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24770,
      "choices": [
        {
          "id": 99041,
          "text": "<p><span style=\"font-size:11.0pt;\">RR &gt;24/min</span></p>"
        },
        {
          "id": 99042,
          "text": "<p><span style=\"font-size:11.0pt;\">MAP 70 mmHg</span></p>"
        },
        {
          "id": 99043,
          "text": "<p><span style=\"font-size:11.0pt;\">Lung infiltrates &gt;42% on CT</span></p>"
        },
        {
          "id": 99044,
          "text": "<p><span style=\"font-size:11.0pt;\">SpO2 &lt; 85% on room air</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which among the following indicates severe COVID-19 ? (INICET MAY 2023)</span></p>",
      "unique_key": "Q9537981",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066901,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;SpO2 &lt; 85% on room air</strong></span></p><p><br><span style=\"font-size:12pt;\">Severe COVID-19 is characterized by a significant drop in oxygen saturation. An SpO2 of less than 85% on room air indicates severe hypoxemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Any SpO2 of less than 90% indicate severe COVID and 90-93% indicates moderate COVID</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. RR &gt;24/min:</strong> Indicates moderate, not severe, COVID-19. RR&gt;30/min indicate severe COVID</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. MAP 70 mmHg:</strong> Does not specifically indicate severe COVID-19. Hemodynamic instability i.e. MAP &lt;65 OR 65 or above with vasopressors indicates severe COVID.&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Lung infiltrates &gt;42% on CT:</strong> Not a specific criterion for COVID-19 severity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Severe COVID-19 is indicated by an SpO2 of less than 85% on room air.</span></p>",
      "correct_choice_id": 99044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11614,
      "choices": [
        {
          "id": 46422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polyneuropathy</span></span></span></p>"
        },
        {
          "id": 46423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiculopathy</span></span></span></p>"
        },
        {
          "id": 46424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Upper motor neuron</span></span></span></p>"
        },
        {
          "id": 46425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lower motor neuron</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The following clinical examination was performed. What lesion would cause an exaggerated reflex?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154119.png\" style=\"height:141px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5947239",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066914,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Upper motor neuron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical examination shown in the image involves testing the ankle jerk reflex, which is a deep tendon reflex. Exaggerated or hyperactive reflexes are typically a sign of an upper motor neuron (UMN) lesion. UMN lesions occur in the neural pathways above the level of the anterior horn cell in the spinal cord, which includes the brain and the spinal cord itself. When these pathways are damaged, there is a loss of inhibitory control over the lower motor neurons, leading to hyperreflexia (exaggerated reflexes).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper motor neuron lesions</span></strong><span style=\"font-size:12.0pt\"> are characterized by:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperreflexia (exaggerated reflexes)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spasticity</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Positive Babinski sign</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Weakness without significant muscle atrophy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Polyneuropathy</strong>: This condition affects multiple peripheral nerves and is typically associated with diminished or absent reflexes rather than exaggerated reflexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Radiculopathy</strong>: Damage to the nerve roots also results in lower motor neuron signs, including reduced reflexes and weakness in the distribution of the affected nerve root.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Lower motor neuron</strong>: Lesions here cause diminished or absent reflexes due to direct damage to the anterior horn cells or peripheral nerves that innervate muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exaggerated reflexes, such as an exaggerated ankle jerk reflex, are indicative of an upper motor neuron lesion. Lower motor neuron lesions, including those caused by polyneuropathy and radiculopathy, typically result in diminished or absent reflexes.</span></span></span></p>",
      "correct_choice_id": 46424,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24777,
      "choices": [
        {
          "id": 99069,
          "text": "<p><span style=\"font-size:11.0pt;\">Centromeric</span></p>"
        },
        {
          "id": 99070,
          "text": "<p><span style=\"font-size:11.0pt;\">Homogenous</span></p>"
        },
        {
          "id": 99071,
          "text": "<p><span style=\"font-size:11.0pt;\">Speckled</span></p>"
        },
        {
          "id": 99072,
          "text": "<p><span style=\"font-size:11.0pt;\">Nucleolar</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the type of ANA staining pattern shown in the image below? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152907.png\" alt=\"\" width=\"300\" height=\"294\"></span></p>",
      "unique_key": "Q9858959",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066912,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Centromeric</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The centromeric pattern is characterized by distinct dots in the nucleus, corresponding to centromeres during cell division. This pattern is associated with <strong>anti-centromere antibodies (ACA)</strong>, commonly seen in limited cutaneous scleroderma (CREST syndrome). ACA antibody&nbsp;is&nbsp; correlate with pulmonary hypertension seen in patients with limited disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Homogenous:</strong> Diffuse staining of the nucleus, seen with anti-ds DNA antibodies or anti-histone antibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Speckled</strong>: Numerous fine or coarse speckles, a kind of quite nonspecific, associated with various antibodies such as anti-SEL70, anti-JOAN, and anti-SMITH antibodies, etc</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nucleolar</strong>: Prominent nucleolar staining, quite nonspecific, seen with Anti-PM-Scl antibody, an overlap antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Centromeric pattern in ANA staining is associated with anti-centromere antibodies and limited scleroderma.</span></p>",
      "correct_choice_id": 99069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54275,
      "choices": [
        {
          "id": 216569,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrochlorothiazide</span></p>"
        },
        {
          "id": 216570,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
        },
        {
          "id": 216571,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 216572,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A diabetic elderly man presents with dyspnea and pedal edema. A chest X-ray (CXR) shows an enlarged heart with rales. Echo reveals a low ejection fraction (EF). Which of the following treatments will delay the progression of cardiac disease?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9092463",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066861,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Empagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Empagliflozin is a medication that belongs to the class of sodium-glucose co-transporter-2 (SGLT2) inhibitors. Although it is primarily used to manage diabetes by promoting glucose excretion through urine, it has been found to have significant benefits in patients with heart failure, particularly those with reduced ejection fraction (HFrEF).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action in Heart Failure:</strong> Empagliflozin improves cardiac outcomes through several mechanisms:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Reduction in preload and afterload:</strong> By promoting diuresis and natriuresis, empagliflozin reduces the volume overload, which is beneficial in heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Improvement in myocardial metabolism:</strong> It shifts myocardial substrate utilization from glucose to ketone bodies, which is more energy-efficient for the failing heart.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reduction in cardiac fibrosis and inflammation:</strong> Empagliflozin has anti-inflammatory and anti-fibrotic effects, which help in reducing cardiac remodeling and progression of heart failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hydrochlorothiazide:</strong> This is a thiazide diuretic primarily used to manage hypertension and mild fluid retention. However, it does not have significant benefits in delaying the progression of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Furosemide:</strong> Furosemide is a loop diuretic used for symptomatic relief of fluid overload in heart failure but does not specifically alter the progression of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Digoxin:</strong> Digoxin is used in heart failure to improve symptoms and control ventricular rate in atrial fibrillation, but it does not have a mortality benefit or significantly delay the progression of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Empagliflozin, although primarily an anti-diabetic medication, has been shown to significantly benefit patients with heart failure with reduced ejection fraction (HFrEF) by delaying the progression of the disease through its effects on diuresis, myocardial metabolism, and cardiac remodeling.</span></p>",
      "correct_choice_id": 216570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24764,
      "choices": [
        {
          "id": 99017,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr; 1 &rarr; 2</span></span></p>"
        },
        {
          "id": 99018,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 &rarr; 2 &rarr; 1</span></span></p>"
        },
        {
          "id": 99019,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 &rarr; 1 &rarr; 3</span></span></p>"
        },
        {
          "id": 99020,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &rarr; 2 &rarr; 3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Order in which the following heart sounds are heard from superior to inferior on the left side chest wall? </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.Pulmonary area</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2.Erb&rsquo;s area</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3.Mitral area</span></span></span></p>",
      "unique_key": "Q9702202",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066895,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 1 &rarr; 2 &rarr; 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The heart sounds are heard in the following order from superior to inferior on the left side chest wall: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary area: 2nd intercostal space near the sternum </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erb&rsquo;s area (2<sup>nd</sup> aortic area): 3rd intercostal space near the sternum </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">&rarr;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Mitral area: 4th intercostal space at the midclavicular line (away from sternum).</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct order from superior to inferior for heart sounds on the left side chest wall is pulmonary area, Erb&rsquo;s area, and mitral area.</span></span></span></p>",
      "correct_choice_id": 99020,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54277,
      "choices": [
        {
          "id": 216577,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal Calcium</span></p>"
        },
        {
          "id": 216578,
          "text": "<p><span style=\"font-size:12.0pt;\">Low Phosphate</span></p>"
        },
        {
          "id": 216579,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine Ca</span> <span style=\"font-size:12.0pt;\">ratio &gt; 0.15</span></p>"
        },
        {
          "id": 216580,
          "text": "<p><span style=\"font-size:12.0pt;\">High PTH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false regarding Nutritional Rickets?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1943230",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066863,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Urine Ca</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>ratio &gt; 0.15</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nutritional rickets is a disorder caused by vitamin D deficiency, leading to impaired bone mineralization and growth. The incorrect statement in the context of nutritional rickets is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is typically seen in primary hyperparathyroidism, not in secondary hyperparathyroidism like that seen in vitamin D deficiency or nutritional rickets. In nutritional rickets, the urine calcium-to-creatinine ratio is usually low because of the body's attempt to conserve calcium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following points summarize the key biochemical features of nutritional rickets:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Normal Calcium:</strong> In many cases of nutritional rickets, serum calcium levels are normal or low-normal at the time of presentation due to secondary hyperparathyroidism, which compensates for the low calcium by increasing parathyroid hormone (PTH) levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Low Phosphate:</strong> Hypophosphatemia is common in rickets due to decreased intestinal absorption of phosphate and increased renal excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. High PTH:</strong> Secondary hyperparathyroidism occurs as a response to hypocalcemia, leading to elevated PTH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In nutritional rickets, the urine calcium-to-creatinine ratio is typically low, not high. Elevated PTH, low phosphate, and normal calcium levels are typical biochemical findings in this condition.</span></p>",
      "correct_choice_id": 216579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54270,
      "choices": [
        {
          "id": 216549,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathyroid gland and hyperparathyroidism</span></span></p>"
        },
        {
          "id": 216550,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid and Hypothyroidism</span></span></p>"
        },
        {
          "id": 216551,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal and Pheochromocytoma</span></span></p>"
        },
        {
          "id": 216552,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone and Metabolic Bone Disease</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-year-old patient presented with proximal weakness, lethargy, low/depressed mood, and recurrent renal stones. Laboratory testing revealed a normal S. Calcium and increased PTH levels. What is the organ involved and the pathology?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7122800",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066932,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Parathyroid gland and hyperparathyroidism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation of proximal weakness, lethargy, low mood, and recurrent renal stones, combined with laboratory findings of normal serum calcium and increased parathyroid hormone (PTH) levels, is indicative of primary hyperparathyroidism. Primary hyperparathyroidism is typically associated with hypercalcemia, but there is a variant known as normocalcemic primary hyperparathyroidism. In this condition, patients exhibit elevated PTH levels while maintaining normal serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Features:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Proximal Weakness and Lethargy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Common symptoms of hyperparathyroidism due to muscle weakness and fatigue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low/Depressed Mood:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Psychiatric manifestations are frequently seen in hyperparathyroidism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recurrent Renal Stones:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hyperparathyroidism leads to increased calcium excretion, resulting in kidney stones.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal Serum Calcium and Increased PTH:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In normocalcemic primary hyperparathyroidism, PTH levels are elevated, but serum calcium levels remain within the normal range.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This condition is a diagnosis of exclusion, meaning other causes of secondary hyperparathyroidism (e.g., vitamin D deficiency, chronic kidney disease) must be ruled out first. Given the absence of clinical findings suggesting vitamin deficiency, osteomalacia, or chronic kidney disease in this case, normocalcemic primary hyperparathyroidism is the most likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Thyroid and Hypothyroidism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hypothyroidism does not present with the combination of symptoms and laboratory findings described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Adrenal and Pheochromocytoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pheochromocytoma typically presents with episodic hypertension, headaches, and palpitations, not the symptoms and lab findings described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Bone and Metabolic Bone Disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While metabolic bone diseases can cause weakness and other symptoms, they do not typically present with elevated PTH and normal calcium as described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normocalcemic primary hyperparathyroidism presents with normal serum calcium and elevated PTH levels and is associated with symptoms like proximal weakness, lethargy, low mood, and recurrent renal stones. It is a diagnosis of exclusion after ruling out other causes of secondary hyperparathyroidism.</span></span></span></p>",
      "correct_choice_id": 216549,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24767,
      "choices": [
        {
          "id": 99029,
          "text": "<p><span style=\"font-size:11.0pt;\">Torsade’s de pointes</span></p>"
        },
        {
          "id": 99030,
          "text": "<p><span style=\"font-size:11.0pt;\">Ventricular fibrillation</span></p>"
        },
        {
          "id": 99031,
          "text": "<p><span style=\"font-size:11.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 99032,
          "text": "<p><span style=\"font-size:11.0pt;\">Monomorphic ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the given ECG? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-133825.png\" alt=\"\" width=\"300\" height=\"227\"></span></p>",
      "unique_key": "Q4433131",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066898,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Torsade’s de pointes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes is characterized by a polymorphic ventricular tachycardia with varying QRS complex amplitudes and a twisting around the baseline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ventricular fibrillation:</strong> Characterized by a chaotic and irregular waveform without identifiable QRS complexes.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Atrial flutter</strong>: Shows a sawtooth pattern of atrial activity.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Monomorphic ventricular tachycardia:</strong> Shows uniform QRS complexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Torsade’s de pointes are a type of polymorphic ventricular tachycardia with a characteristic twisting pattern.</span></p>",
      "correct_choice_id": 99029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54271,
      "choices": [
        {
          "id": 216553,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></p>"
        },
        {
          "id": 216554,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone</span></span></p>"
        },
        {
          "id": 216555,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></p>"
        },
        {
          "id": 216556,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs used in the management of type 2 diabetes is associated with an increased risk of urinary tract infections?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8655124",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066933,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus. SGLT2 inhibitors work by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This mechanism of action results in a higher concentration of glucose in the urinary tract, which can promote bacterial growth and lead to an increased risk of urinary tract infections (UTIs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Pioglitazone:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This drug is a thiazolidinedione that improves insulin sensitivity but is not associated with an increased risk of UTIs. Instead, it can cause side effects such as fluid retention, weight gain, and an increased risk of bladder cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sitagliptin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases insulin release and decreases glucagon levels in the bloodstream. It is associated with risks such as pancreatitis and gastrointestinal disturbances but not with an increased risk of UTIs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Metformin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is a biguanide that decreases hepatic glucose production and increases insulin sensitivity. Common side effects include gastrointestinal disturbances (e.g., diarrhea) and vitamin B12 deficiency, but it does not increase the risk of UTIs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This highlights the importance of monitoring for UTIs in patients prescribed this medication.</span></span></span></p>",
      "correct_choice_id": 216553,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24778,
      "choices": [
        {
          "id": 99073,
          "text": "<p><span style=\"font-size:11.0pt;\">Vascular disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99074,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease with bronchodilator reversibility</span></p>"
        },
        {
          "id": 99075,
          "text": "<p><span style=\"font-size:11.0pt;\">Restrictive lung disease without bronchodilator reversibility</span></p>"
        },
        {
          "id": 99076,
          "text": "<p><span style=\"font-size:11.0pt;\">Obstructive disease with bronchodilator reversibility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A chronic cigarette smoker now joined a construction company. His pulmonary function test results are given below.(INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Initial lung volumes were: FEV1 - 0.9L, FVC - 1.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">After bronchodilation: FEV1 - 1.9L, FVC - 3.9L, FEV1/FVC - 0.4</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">What is the most likely diagnosis for this patient?</span></p>",
      "unique_key": "Q7107803",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066909,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Obstructive disease with bronchodilator reversibility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pulmonary function test results show a reduced FEV1/FVC ratio, consistent with obstructive lung disease. Significant improvement in FEV1 post-bronchodilation indicates reversibility (FEV1 - anything &gt;200ml is significant), suggesting conditions like asthma or COPD with reversible obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Vascular disease with bronchodilator reversibility</strong>: Pulmonary function tests do not suggest vascular disease.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Restrictive lung disease with bronchodilator reversibility:</strong> Restrictive diseases show reduced volumes but normal or increased FEV1/FVC ratio.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Restrictive lung disease without bronchodilator reversibility</strong>: Not applicable as the patient shows obstructive pattern with reversibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstructive lung diseases, such as asthma or COPD, may show bronchodilator reversibility.</span></p>",
      "correct_choice_id": 99076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11623,
      "choices": [
        {
          "id": 46458,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D toxicity</span></span></span></p>"
        },
        {
          "id": 46459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute pancreatitis</span></span></span></p>"
        },
        {
          "id": 46460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic kidney disease</span></span></span></p>"
        },
        {
          "id": 46461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoparathyroidism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents with perioral numbness, tingling, and tetany. All the following conditions can lead to this, except:</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q9862231",
      "question_audio": null,
      "question_video": null,
      "map_id": 35066917,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Vitamin D toxicity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vitamin D toxicity&nbsp;</span></strong><span style=\"font-size:12.0pt\">leads to <strong>hypercalcemia</strong>, not hypocalcemia. Excessive vitamin D increases calcium absorption from the gastrointestinal tract and mobilizes calcium from bones, leading to elevated serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Perioral numbness, tingling, and tetany are symptoms indicative of hypocalcemia. Various conditions can lead to hypocalcemia, each through different mechanisms:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute Pancreatitis</span></strong><span style=\"font-size:12.0pt\">: This condition can lead to hypocalcemia due to the sequestration of calcium in the inflamed pancreatic tissue and the formation of calcium soaps.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic Kidney Disease</span></strong><span style=\"font-size:12.0pt\">: CKD results in hypocalcemia primarily due to decreased production of calcitriol (active vitamin D). The kidneys are unable to convert 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D, leading to decreased calcium absorption in the gut.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypoparathyroidism</span></strong><span style=\"font-size:12.0pt\">: This condition, often resulting from surgical removal or damage to the parathyroid glands, leads to decreased production of parathyroid hormone (PTH). PTH is crucial for calcium homeostasis, and its deficiency results in hypocalcemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D toxicity causes hypercalcemia, not hypocalcemia, distinguishing it from other conditions that can lead to hypocalcemia.</span></span></span></p>",
      "correct_choice_id": 46458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}